Canopy Growth (CGC) 10-Q 10 Aug 20 2021 Q1 Quarterly report Financial data

Document and Entity Information

Document and Entity Information - shares	3 Months Ended
	Jun. 30, 2020	Aug. 07, 2020
Cover [Abstract]
Document Type	10-Q
Amendment Flag	false
Document Period End Date	Jun. 30, 2020
Document Fiscal Year Focus	2021
Document Fiscal Period Focus	Q1
Entity Registrant Name	Canopy Growth Corporation
Entity Central Index Key	0001737927
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Current Fiscal Year End Date	--03-31
Entity Filer Category	Large Accelerated Filer
Entity Common Stock, Shares Outstanding		371,272,132
Entity Shell Company	false
Entity Small Business	false
Entity Emerging Growth Company	false
Title of 12(b) Security	Common shares, no par value
Trading Symbol	CGC
Security Exchange Name	NYSE
Entity File Number	001-38496
Entity Incorporation, State or Country Code	Z4
Entity Tax Identification Number	00-0000000
Entity Address, Address Line One	1 Hershey Drive
Entity Address, City or Town	Smith Falls
Entity Address, State or Province	ON
Entity Address, Postal Zip Code	K7A 0A8
City Area Code	855
Local Phone Number	558-9333
Document Quarterly Report	true
Document Transition Report	false

Condensed Interim Consolidated

Condensed Interim Consolidated Balance Sheets (Unaudited) - CAD ($) $ in Thousands	Jun. 30, 2020	Mar. 31, 2020
Current assets:
Cash and cash equivalents	$ 975,870	$ 1,303,176
Short-term investments	1,060,901	673,323
Restricted short-term investments	16,436	21,539
Amounts receivable, net	72,578	90,155
Inventory	389,800	391,086
Prepaid expenses and other assets	98,362	85,094
Total current assets	2,613,947	2,564,373
Equity method investments	58,654	65,843
Other financial assets	273,624	249,253
Property, plant and equipment	1,508,668	1,524,803
Intangible assets	444,199	476,366
Goodwill	1,929,418	1,954,471
Other assets	17,320	22,636
Total assets	6,845,830	6,857,745
Current liabilities:
Accounts payable	89,368	123,393
Other accrued expenses and liabilities	82,981	64,994
Current portion of long-term debt	22,570	16,393
Other liabilities	124,757	215,809
Total current liabilities	319,676	420,589
Long-term debt	477,836	449,022
Deferred income tax liabilities	45,816	47,113
Other liabilities	168,239	190,660
Total liabilities	1,583,689	1,679,875
Commitments and contingencies
Redeemable noncontrolling interest	81,600	69,750
Canopy Growth Corporation shareholders' equity:
Common shares - $nil par value; Authorized - unlimited number of shares; Issued - 370,865,639 shares and 350,112,927 shares, respectively	6,724,245	6,373,544
Additional paid-in capital	2,520,371	2,615,155
Accumulated other comprehensive income	152,415	220,899
Deficit	(4,431,737)	(4,323,236)
Total Canopy Growth Corporation shareholders' equity	4,965,294	4,886,362
Noncontrolling interests	215,247	221,758
Total shareholders' equity	5,180,541	5,108,120
Total liabilities and shareholders' equity	6,845,830	6,857,745
Acreage
Current liabilities:
Liability arising from Acreage Arrangement	285,000	250,000
Warrant
Current liabilities:
Derivative liability	$ 287,122	$ 322,491

Condensed Interim Consolidate_2

Condensed Interim Consolidated Balance Sheets (Parenthetical) (Unaudited) - shares	Jun. 30, 2020	Mar. 31, 2020
Statement Of Financial Position [Abstract]
Common stock, shares issued	370,865,639	350,112,927

Condensed Interim Consolidate_3

Condensed Interim Consolidated Statements of Operations and Comprehensive Loss (Unaudited) - CAD ($) $ in Thousands	3 Months Ended
	Jun. 30, 2020	Jun. 30, 2019
Income Statement [Abstract]
Revenue	$ 119,088	$ 103,391
Excise taxes	8,672	12,909
Net revenue	110,416	90,482
Cost of goods sold	103,921	72,192
Gross margin	6,495	18,290
Operating expenses
Selling, general and administrative expenses	135,392	145,647
Share-based compensation	30,685	87,362
Asset impairment and restructuring costs	12,794
Total operating expenses	178,871	233,009
Operating loss	(172,376)	(214,719)
Loss from equity method investments	(7,189)	(1,833)
Other income (expense), net	48,205	32,768
Loss before income taxes	(131,360)	(183,784)
Income tax recovery (expense)	3,038	(10,267)
Net loss	(128,322)	(194,051)
Net loss attributable to noncontrolling interests and redeemable noncontrolling interest	(19,821)	(8,182)
Net loss attributable to Canopy Growth Corporation	$ (108,501)	$ (185,869)
Basic and diluted loss per share	$ (0.30)	$ (0.54)
Basic and diluted weighted average common shares outstanding	363,763,347	346,779,156
Comprehensive loss:
Net loss	$ (128,322)	$ (194,051)
Other comprehensive (loss) income, net of income tax effect
Fair value changes of own credit risk of financial liabilities	(15,360)	14,610
Foreign currency translation	(53,124)	(60,744)
Total other comprehensive loss, net of income tax effect	(68,484)	(46,134)
Comprehensive loss	(196,806)	(240,185)
Comprehensive loss attributable to noncontrolling interests and redeemable noncontrolling interest	(19,821)	(8,182)
Comprehensive loss attributable to Canopy Growth Corporation	$ (176,985)	$ (232,003)

Condensed Interim Consolidate_4

Condensed Interim Consolidated Statements of Shareholder's Equity (Unaudited) - CAD ($) $ in Thousands	Total	Common Shares	Additional Paid-in capitalShare-based Reserve	Additional Paid-in capitalWarrant	Additional Paid-in capitalOwnership Changes	Additional Paid-in capitalRedeemable Noncontrolling Interest	Accumulated Other Comprehensive Income (Loss)	Deficit	Noncontrolling Interests
Beginning balance at Mar. 31, 2019	$ 7,065,708	$ 6,029,222	$ 505,172	$ 1,589,925	$ (500,963)	$ (2,110)	$ (5,905)	$ (835,118)	$ 285,485
Other issuances of common shares and warrants	(74)	18,600	(18,674)
Exercise of warrants	427	897		(470)
Exercise of Omnibus Plan stock options	16,077	28,671	(12,594)
Share-based compensation	84,769		84,769
Acreage warrant modification	(1,117,639)			1,049,153				(2,166,792)
Changes in redeemable noncontrolling interest	(2,100)					615			(2,715)
Ownership changes relating to noncontrolling interests	2,680				(150)				2,830
Comprehensive loss	(240,185)						(46,134)	(185,869)	(8,182)
Ending balance at Jun. 30, 2019	5,809,663	6,077,390	558,673	2,638,608	(501,113)	(1,495)	(52,039)	(3,187,779)	277,418
Beginning balance at Mar. 31, 2020	5,108,120	6,373,544	517,741	2,638,951	(501,403)	(40,134)	220,899	(4,323,236)	221,758
Other issuances of common shares and warrants	(584)	26,214	(26,798)
Exercise of warrants	244,990	315,256		(70,266)
Exercise of Omnibus Plan stock options	4,722	9,231	(4,509)
Share-based compensation	29,140		29,140
Changes in redeemable noncontrolling interest	(11,850)					(22,513)			10,663
Ownership changes relating to noncontrolling interests	2,809				162				2,647
Comprehensive loss	(196,806)						(68,484)	(108,501)	(19,821)
Ending balance at Jun. 30, 2020	$ 5,180,541	$ 6,724,245	$ 515,574	$ 2,568,685	$ (501,241)	$ (62,647)	$ 152,415	$ (4,431,737)	$ 215,247

Condensed Interim Consolidate_5

Condensed Interim Consolidated Statements of Cash Flows (Unaudited) - CAD ($) $ in Thousands	3 Months Ended
	Jun. 30, 2020	Jun. 30, 2019
Cash flows from operating activities:
Net loss	$ (128,322)	$ (194,051)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation of property, plant and equipment	17,415	13,587
Amortization of intangible assets	16,632	7,165
Share of loss on equity method investments	7,189	1,833
Share-based compensation	30,685	87,362
Asset impairment and restructuring costs	12,794
Income tax (recovery) expense	(3,038)	10,267
Non-cash foreign currency	8,688	2,834
Change in operating assets and liabilities, net of effects from purchases of businesses:
Amounts receivable	17,577	13,506
Prepaid expenses and other assets	(16,059)	(24,009)
Inventory	(10,772)	(50,716)
Accounts payable and accrued liabilities	3,755	(12,582)
Other, including non-cash fair value adjustments	(75,090)	(13,486)
Net cash used in operating activities	(118,546)	(158,290)
Cash flows from investing activities:
Purchases of and deposits on property, plant and equipment	(61,547)	(211,824)
Purchases of intangible assets	(3,088)	(7,692)
Proceeds on sale of intangible assets	18,337
(Purchases) redemption of short-term investments	(382,486)	687,818
Investments in equity method investments		(2,824)
Investments in other financial assets	(2,564)	(29,414)
Investment in Acreage Arrangement		(395,190)
Recovery of amounts related to construction financing	10,000
Payment of acquisition related liabilities	(4,511)	(21,447)
Net cash outflow on acquisition of noncontrolling interests	(125)
Net cash outflow on acquisition of subsidiaries		(425,024)
Net cash used in investing activities	(425,984)	(405,597)
Cash flows from financing activities:
Payment of share issue costs	(595)	(74)
Proceeds from issuance of shares by Canopy Rivers	92	86
Proceeds from exercise of stock options	4,722	16,077
Proceeds from exercise of warrants	244,990	427
Issuance of long-term debt	4,439
Repayment of long-term debt	(6,345)	(98,207)
Net cash provided by (used in) financing activities	247,303	(81,691)
Effect of exchange rate changes on cash and cash equivalents	(30,079)	(18,620)
Net decrease in cash and cash equivalents	(327,306)	(664,198)
Cash and cash equivalents, beginning of period	1,303,176	2,480,830
Cash and cash equivalents, end of period	975,870	1,816,632
Cash received during the period:
Income taxes	2,000
Cash paid during the period:
Income taxes	408
Noncash investing and financing activities
Additions to property, plant and equipment	$ 17,337	$ 124,427

Description of Business

Description of Business	3 Months Ended
	Jun. 30, 2020
Organization Consolidation And Presentation Of Financial Statements [Abstract]
Description of Business	1 Canopy Growth Corporation is a publicly traded corporation, incorporated in Canada, with its head office located at 1 Hershey Drive, Smiths Falls, Ontario. References in these condensed interim consolidated financial statements to “Canopy Growth” or “the Company” refer to Canopy Growth Corporation and its subsidiaries. The principal activities of the Company are the production, distribution and sale of cannabis as regulated by the Access to Cannabis for Medical Purposes Regulations (“ACMPR”) in Canada, up to and including October 16, 2018. On October 17, 2018, the ACMPR was superseded by The Cannabis Act which regulates the production, distribution, and possession of cannabis for both medical and adult recreational access in Canada. The Company is also expanding to jurisdictions outside of Canada where federally lawful and regulated for cannabis and/or hemp including subsidiaries which operate in the United States, Europe, Latin America and the Caribbean, and Asia / Pacific. Through its partially owned subsidiary Canopy Rivers Inc. (“Canopy Rivers”), the Company also provides growth capital and a strategic support platform that pursues investment opportunities in the global cannabis sector, where federally lawful.

Basis of Presentation

Basis of Presentation	3 Months Ended
	Jun. 30, 2020
Organization Consolidation And Presentation Of Financial Statements [Abstract]
Basis of Presentation	2 These condensed interim consolidated financial statements have been presented in Canadian dollars and are prepared in accordance with accounting principles generally accepted in the United States of America (“U.S. GAAP”). Canopy Growth has determined that the Canadian dollar is the most relevant and appropriate reporting currency as, despite continuing shifts in the relative size of our operations across multiple geographies, the majority of our operations are conducted in Canadian dollars and our financial results are prepared and reviewed internally by management in Canadian dollars. Our condensed interim consolidated financial statements, and the financial information contained herein, are reported in thousands of Canadian dollars, except share and per share amounts or as otherwise stated. Certain information and footnote disclosures normally included in the audited annual consolidated financial statements prepared in accordance with U.S. GAAP have been omitted or condensed. These condensed interim consolidated financial statements should be read in conjunction with the audited consolidated financial statements included in the Company’s Annual Report on Form 10-K for the year ended March 31, 2020 (the “Annual Report”), and have been prepared on a basis consistent with the accounting policies as described in the Annual Report. These condensed interim consolidated financial statements are unaudited and reflect adjustments (consisting of normal recurring adjustments) that are, in the opinion of management, necessary to provide a fair statement of results for the interim periods in accordance with U.S. GAAP. The results reported in these condensed interim consolidated financial statements should not be regarded as necessarily indicative of results that may be expected for an entire fiscal year. The policies set out below are consistently applied to all periods presented, unless otherwise noted. Principles of consolidation The accompanying condensed interim consolidated financial statements include the accounts of the Company and all entities in which the Company either has a controlling voting interest or is the primary beneficiary of a variable interest entity. All intercompany accounts and transactions have been eliminated on consolidation. Information on the Company’s subsidiaries with noncontrolling interests is included in Note 21. Variable interest entities A variable interest entity (“VIE”) is an entity that does not have sufficient equity at risk to finance its activities without additional subordinated financial support or is structured such that equity investors lack the ability to control the entity’s activities or do not substantially participate in the gains and losses of the entity. Upon inception of a contractual agreement, and thereafter, if a reconsideration event occurs, the Company performs an assessment to determine whether the arrangement contains a variable interest in an entity and whether that entity is a VIE. The primary beneficiary of a VIE is the party that has both the power to direct the activities that most significantly impact the VIE’s economic performance and the obligation to absorb losses or the right to receive benefits from the VIE that could potentially be significant to the VIE. Under Accounting Standards Codification (“ASC”) 810 – Consolidations Equity method investments Investments accounted for using the equity method include those investments where the Company (i) can exercise significant influence over the other entity and (ii) holds common stock and/or in-substance common stock of the other entity. Under the equity method, investments are carried at cost, and subsequently adjusted for the Company’s share of net income (loss), comprehensive income (loss) and distributions received from the investee. If the current fair value of an investment falls below its carrying amount, this may indicate that an impairment loss should be recorded. Any impairment losses recognized are not reversed in subsequent periods. Refer to Note 9 for additional information on the Company’s investments accounted for using the equity method. Use of estimates The preparation of these condensed interim consolidated financial statements and accompanying notes in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the amounts reported. Actual results could differ from those estimates. New accounting policies Recently Adopted Accounting Pronouncements Measurement of Credit Losses on Financial Instruments In June 2016, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU”) 2016-13, Financial Instruments – Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments Canopy Growth adopted the new standard as of April 1, 2020. There was no impact of adopting ASU 2016-13 on the condensed interim consolidated financial statements. Fair Value Measurement In August 2018, the FASB issued ASU 2018-13, Disclosure Framework – Changes to the Disclosure Requirements for Fair Value Measurement (Topic 820) Accounting Guidance not yet adopted Income Taxes In December 2019, the FASB issued ASU 2019-12, Income Taxes (Topic 740): Simplifying the Accounting for Income Taxes In January 2020, the FASB issued ASU 2020-01, Investments-Equity Securities (Topic 321), Investments-Equity Method and Joint Ventures (Topic 323), and Derivatives and Hedging (Topic 815)

Asset Impairment and Restructur

Asset Impairment and Restructuring Costs	3 Months Ended
	Jun. 30, 2020
Restructuring And Related Activities [Abstract]
Asset Impairment and Restructuring Costs	3. ASSET IMPAIRMENT AND RESTRUCTURING COSTS In the year ended March 31, 2020, the Company commenced an organizational and strategic review of its business which resulted in several restructuring actions designed to improve organizational focus, streamline operations and align the Company’s production capability with projected demand. In the three months ended June 30, 2020, the Company completed certain of the restructuring actions that had commenced in the previous fiscal year, and recorded final adjustments related to changes in certain estimates recorded at March 31, 2020. In addition, the Company incurred additional costs in the three months ended June 30, 2020, related primarily to the rationalization of our marketing organization in the current period. As a result, in the three months ended June 30, 2020, the Company recognized asset impairment and restructuring costs of $12,794 in relation to (i) costs associated with the closure of certain of the Company’s Canadian production facilities; (ii) completing the exit of the Company’s operations in South Africa and Lesotho; and (iii) employee-related costs associated with rationalizing certain marketing activities.

Cash and Cash Equivalents

Cash and Cash Equivalents	3 Months Ended
	Jun. 30, 2020
Cash And Cash Equivalents [Abstract]
Cash and Cash Equivalents	4. CASH AND CASH EQUIVALENTS The components of cash and cash equivalents are as follows: June 30, March 31, 2020 2020 Cash $ 508,047 $ 679,581 Cash equivalents 467,823 623,595 $ 975,870 $ 1,303,176

Short-term Investments

Short-term Investments	3 Months Ended
	Jun. 30, 2020
Short Term Investments [Abstract]
Short-term Investments	5. SHORT-TERM INVESTMENTS The components of short-term investments are as follows: June 30, March 31, 2020 2020 Term deposits $ 626,470 $ 374,000 Government securities 195,789 226,087 Commercial paper and other 238,642 73,236 $ 1,060,901 $ 673,323 The amortized cost of short-term investments at June 30, 2020 is $1,060,890 (March 31, 2020 – $673,022).

Amounts Receivable, Net

Amounts Receivable, Net	3 Months Ended
	Jun. 30, 2020
Receivables [Abstract]
Amounts Receivable, Net	6. AMOUNTS RECEIVABLE, NET The components of amounts receivable, net are as follows: June 30, March 31, 2020 2020 Accounts receivable, net $ 42,222 $ 51,166 Interest receivable 14,215 10,303 Indirect taxes receivable 5,348 22,982 Other receivables 10,793 5,704 $ 72,578 $ 90,155 Included in the accounts receivable, net balance at June 30, 2020 is an allowance for doubtful accounts of $917 (March 31, 2020 – $655)

Inventory

Inventory	3 Months Ended
	Jun. 30, 2020
Inventory Disclosure [Abstract]
Inventory	7. INVENTORY The components of inventory are as follows: June 30, March 31, 2020 2020 Raw materials, packaging supplies and consumables $ 49,581 $ 75,507 Work in progress 260,028 255,934 Finished goods 80,191 59,645 $ 389,800 $ 391,086 In the three months ended June 30, 2020, the Company recorded write-downs related to inventory of $19,386 (three months ended June 30, 2019 – $4,789)

Prepaid Expenses and Other Asse

Prepaid Expenses and Other Assets	3 Months Ended
	Jun. 30, 2020
Prepaid Expense And Other Assets Current [Abstract]
Prepaid Expenses and Other Assets	8. PREPAID EXPENSES AND OTHER ASSETS The components of prepaid expenses and other assets are as follows: June 30, March 31, 2020 2020 Prepaid expenses $ 51,202 $ 41,423 Deposits 18,752 7,773 Prepaid inventory 17,160 21,217 Other assets 11,248 14,681 $ 98,362 $ 85,094

Equity Method Investments

Equity Method Investments	3 Months Ended
	Jun. 30, 2020
Equity Method Investments And Joint Ventures [Abstract]
Equity Method Investments	9. EQUITY METHOD INVESTMENTS The following table presents changes in the Company’s investments in associates that are accounted for using the equity method in the three months ended June 30, 2020: Balance at Share of Balance at Ownership March 31, net (loss) June 30, Entity Instrument percentage 2020 income 2020 PharmHouse Shares 49% $ 37,025 $ (4,656 ) $ 32,369 More Life Shares 40% 10,300 - 10,300 CanapaR Shares 49% 8,500 (329 ) 8,171 Agripharm Shares 40% 5,000 (2,937 ) 2,063 Other Shares 18%-27% 5,018 733 5,751 $ 65,843 $ (7,189 ) $ 58,654 Where the Company does not have the same reporting date as its investees, the Company will account for its investment one quarter in arrears. Accordingly, certain of the figures in the above table, including the Company’s share of the investee’s net income (loss), are based on the investees’ results for the three months ended March 31, 2020 (with respect to June 30, 2020) with adjustments for any signficant transactions. The following tables present current and non-current assets, current and non-current liabilities as well as revenues and net loss of the Company’s equity method investments as at and for the three months ended March 31, 2020: Current Non-current Current Non-current Entity assets assets liabilities liabilities Revenue Net loss PharmHouse $ 9,193 $ 167,022 $ 85,463 $ 80,176 $ - $ (9,019 ) CanapaR 14,006 11,328 2,126 - 110 (669 ) Agripharm 6,992 25,034 25,153 1,719 2,468 (7,342 ) Other 10,317 22,360 3,996 11,462 1,928 (2,588 ) $ 40,508 $ 225,744 $ 116,738 $ 93,357 $ 4,506 $ (19,618 )

Other Financial Assets

Other Financial Assets	3 Months Ended
	Jun. 30, 2020
Schedule Of Investments [Abstract]
Other Financial Assets	10. OTHER FINANCIAL ASSETS The following table outlines changes in other financial assets. Additional details on how the fair value of significant investments are calculated are included in Note 22. Exercise of Balance at options / Balance at March 31, Fair value disposal June 30, Entity Instrument 2020 Additions changes of shares 2020 TerrAscend Canada Term loan / debenture $ 53,820 $ - $ 10,960 $ - $ 64,780 TerrAscend Exchangeable shares 47,000 - 6,000 - 53,000 TerrAscend Warrants 25,004 - 10,306 - 35,310 PharmHouse Loan receivable 40,000 - - - 40,000 ZeaKal Shares 14,186 - (586 ) - 13,600 Agripharm Royalty interest 12,600 - 900 - 13,500 Greenhouse Convertible debenture 10,517 - (17 ) - 10,500 Other - classified as fair value through net income (loss) Various 22,495 481 (4,628 ) - 18,348 Other - elected as fair value through net income (loss) Various 9,483 1,519 (1,128 ) - 9,874 Other - classified as held for investment Loan receivable 14,148 600 - (36 ) 14,712 $ 249,253 $ 2,600 $ 21,807 $ (36 ) $ 273,624

Property, Plant and Equipment

Property, Plant and Equipment	3 Months Ended
	Jun. 30, 2020
Property Plant And Equipment [Abstract]
Property, Plant and Equipment	11. PROPERTY, PLANT AND EQUIPMENT The components of property, plant and equipment are as follows: June 30, March 31, 2020 2020 Buildings and greenhouses $ 880,329 $ 876,732 Production and warehouse equipment 287,002 300,666 Leasehold improvements 76,862 75,964 Land 71,355 65,003 Office and lab equipment 28,538 29,978 Computer equipment 31,844 30,744 Right-of-use-assets Buildings and greenhouses 148,743 169,754 Production and warehouse equipment 666 927 Assets in process 371,626 365,644 1,896,965 1,915,412 Less: Accumulated depreciation (388,297 ) (390,609 ) $ 1,508,668 $ 1,524,803 Depreciation expense included in cost of goods sold for the three months ended June 30, 2020 is $14,786 (three months ended June 30, 2019 – $9,316). Depreciation expense included in selling, general and administrative expenses for the three months ended June 30, 2020 is $2,629 (three months ended June 30, 2019 – $4,271).

Intangible Assets

Intangible Assets	3 Months Ended
	Jun. 30, 2020
Intangible Assets Net Excluding Goodwill [Abstract]
Intangible Assets	12. INTANGIBLE ASSETS The components of intangible assets are as follows: June 30, 2020 March 31, 2020 Gross Net Gross Net Carrying Carrying Carrying Carrying Amount Amount Amount Amount Finite lived intangible assets Licensed brands $ 65,826 $ 49,218 $ 66,227 $ 53,797 Distribution channel 73,721 43,622 74,768 47,117 Health Canada and operating licenses 56,200 49,132 63,631 57,250 Intellectual property 220,142 190,843 240,386 215,044 Software and domain names 24,238 17,966 16,056 10,013 Amortizable intangibles in process 4,083 4,083 9,590 9,590 Total 444,210 354,864 470,658 392,811 Indefinite lived intangible assets Operating licenses $ 8,000 $ 7,000 Acquired brands 81,335 76,555 Total intangible assets $ 444,199 $ 476,366 Amortization expense included in cost of goods sold for the three months ended June 30, 2020 is $702 (three months ended June 30, 2019 – $12). Amortization expense included in selling, general and administrative expenses for the three months ended June 30, 2020 is $15,930 (three months ended June 30, 2019 – $7,153

Goodwill

Goodwill	3 Months Ended
	Jun. 30, 2020
Goodwill And Intangible Assets Disclosure [Abstract]
Goodwill	13. GOODWILL The changes in the carrying amount of goodwill are as follows: Balance, March 31, 2019 $ 1,489,859 Purchase accounting allocations 443,724 Finalization of S&B purchase price allocation (24,990 ) Foreign currency translation adjustments 45,878 Balance, March 31, 2020 1,954,471 Foreign currency translation adjustments (25,053 ) Balance, June 30, 2020 $ 1,929,418

Other Accrued Expenses and Liab

Other Accrued Expenses and Liabilities	3 Months Ended
	Jun. 30, 2020
Accounts Payable And Accrued Liabilities Current [Abstract]
Other Accrued Expenses and Liabilities	14. OTHER ACCRUED EXPENSES AND LIABILITIES The components of other accrued expenses and liabilities are as follows: June 30, March 31, 2020 2020 Property, plant and equipment $ 2,576 $ 1,173 Professional fees 15,725 7,677 Employee compensation 41,036 33,415 Other 23,644 22,729 $ 82,981 $ 64,994

Debt

Debt	3 Months Ended
	Jun. 30, 2020
Debt Disclosure [Abstract]
Debt	15. DEBT The components of debt are as follows: Convertible senior notes June 30, March 31, Maturity Date 2020 2020 Convertible senior notes at 4.25% interest with semi-annual interest payments July 15, 2023 Principal amount $ 600,000 $ 600,000 Accrued interest 11,898 5,454 Non-credit risk fair value adjustment (13,230 ) (27,120 ) Credit risk fair value adjustment (112,770 ) (128,130 ) 485,898 450,204 Transferred receivables, bearing interest rate of EURIBOR plus 0.850% 4,439 4,678 Other revolving debt facility, loan, and financings 10,069 10,533 500,406 465,415 Less: current portion (22,570 ) (16,393 ) Long-term portion $ 477,836 $ 449,022 On June 20, 2018, the Company issued convertible senior notes (the “notes”) with an aggregate principal amount of $600,000. The notes bear interest at a rate of 4.25% per annum, payable semi-annually on January 15th and July 15th of each year commencing from January 15, 2019. The notes will mature on July 15, 2023. The notes are subordinated in right of payment to any existing and future senior indebtedness, including indebtedness under the revolving credit facility. The notes will rank senior in right of payment to any future subordinated borrowings. The notes are effectively junior to any secured indebtedness and the notes are structurally subordinated to all indebtedness and other liabilities of the Company’s subsidiaries. Holders of the notes may convert the notes at their option at any time from January 15, 2023 to the maturity date. The notes will be convertible, at the holder’s option, at a conversion rate of 20.7577 common shares for every $1 principal amount of notes (equal to an initial conversion price of approximately $48.18 per common share), subject to adjustments in certain events. In addition, the holder has the right to exercise the conversion option from September 30, 2018 to January 15, 2023, if (i) the market price of the Company common shares for at least 20 trading days during a period of 30 consecutive trading days ending on the last trading day of the preceding calendar quarter is greater than or equal to 130% of the conversion price on each applicable trading day, (ii) during the 5 business day period after any consecutive 5 trading day period (the “measurement period”) in which the trading price per $1 principal amount of the notes for each trading day in the measurement period was less than 98% of the product of the last reported sales price of the Company’s common shares and the conversion rate on each such trading day, (iii) the notes are called for redemption or (iv) upon occurrence of certain corporate events (“Fundamental Change”). A Fundamental Change occurred upon completion of the investment by Constellation Brands, Inc. (“CBI”) in November 2018, and no note holders surrendered any portion of their notes as at the repurchase date of December 5, 2018 . The Company may, upon conversion by the holder, elect to settle in either cash, common shares, or a combination of cash and common shares, subject to certain circumstances. Under the terms of the indenture if a Fundamental Change occurs and a holder elects to convert its notes from and including on the date of the Fundamental Change up to, and including, the business day immediately prior to the Fundamental Change repurchase date, the Company may be required to increase the conversion rate for the notes so surrendered for conversion by a number of additional common shares. The Company cannot redeem the notes prior to July 20, 2021, except in the event of certain changes in Canadian tax law. On or after July 20, 2021, the Company could redeem for cash, subject to certain conditions, any or all of the notes, at its option, if the last reported sales price of the Company’s common shares for at least 20 trading days during any 30 consecutive trading day period ending within 5 trading days immediately preceding the date on which the Company provides notice of redemption exceeds 130% of the conversion price on each applicable trading day. The Company may also redeem the notes, if certain tax laws related to Canadian withholding tax change subject to certain further conditions. The redemption of notes in either case shall be at a redemption price equal to 100% of the principal amount of the notes to be redeemed, plus accrued and unpaid interest to, but excluding, the redemption date. For accounting purposes, the equity conversion feature did not meet the equity classification guidance, therefore the Company elected the fair value option under ASC 825 – Fair Value Measurements The overall change in fair value of the notes during the three months ended June 30, 2020, was an increase of $35,694 (three months ended June 30, 2019 a decrease of $46,056), which included contractual interest of $6,444 (three months ended June 30, 2019, interest of $6,444). Refer to Note 22 for additional details on how the fair value of the notes is calculated. Transferred receivables The carrying amount of the transferred receivables include receivables which are subject to a factoring arrangement. Under this agreement, C 3 3 Other revolving debt facility, loans, and financings On August 13, 2019, the Company, through its wholly owned subsidiary, Tweed Farms Inc., entered into a $40,000 revolving debt facility with Farm Credit Canada (“FCC”). The new facility replaces the previous loans with FCC and is secured by the Company’s property in Niagara-on-the-Lake. The extinguishment of $4,912 in previous FCC debt resulted in no gain or loss. The current outstanding balance of the FCC debt facility is $5,268 with an interest rate of 3.45%, or FCC prime rate plus 1.0%, and matures on September 3, 2024. The revolving debt facility with FCC is secured by a first charge on the properties in Niagara-on-the-Lake, Ontario, a corporate guarantee from the Company, and a general corporate security agreement .

Other Liabilities

Other Liabilities	3 Months Ended
	Jun. 30, 2020
Other Liabilities Disclosure [Abstract]
Other Liabilities	16. OTHER LIABILITIES The components of other liabilities are as follows: As at June 30, 2020 As at March 31, 2020 Current Long-term Total Current Long-term Total Acquisition consideration related liabilities $ 52,318 $ 13,749 $ 66,067 $ 104,028 $ 9,791 $ 113,819 Lease liabilities 38,308 97,010 135,318 40,356 120,047 160,403 Minimum royalty obligations 11,437 49,043 60,480 9,368 50,445 59,813 Refund liability 8,433 - 8,433 17,586 - 17,586 Settlement liability 1,411 6,636 8,047 33,162 7,932 41,094 Other 12,850 1,801 14,651 11,309 2,445 13,754 $ 124,757 $ 168,239 $ 292,996 $ 215,809 $ 190,660 $ 406,469

Redeemable Noncontrolling Inter

Redeemable Noncontrolling Interest	3 Months Ended
	Jun. 30, 2020
Temporary Equity Disclosure [Abstract]
Redeemable Noncontrolling Interest	17. REDEEMABLE NONCONTROLLING INTEREST The net changes in the redeemable noncontrolling interests are as follows: Vert Mirabel BioSteel Total As at March 31, 2020 $ 20,250 $ 49,500 $ 69,750 Loss attributable to noncontrolling interest (9,253 ) (1,410 ) (10,663 ) Adjustments to redemption amount 18,803 3,710 22,513 As at June 30, 2020 $ 29,800 $ 51,800 $ 81,600 Vert Mirabel As at March 31, 2019 $ 6,400 Income attributable to noncontrolling interest 2,715 Adjustments to redemption amount (615 ) As at June 30, 2019 $ 8,500

Share Capital

Share Capital	3 Months Ended
	Jun. 30, 2020
Equity [Abstract]
Share Capital	18. SHARE CAPITAL CANOPY GROWTH Authorized An unlimited number of common shares. (i) Equity financings There were no equity financings during the three months ended June 30, 2020 (June 30, 2019 - none). (ii) Other issuances of common shares During the three months ended June 30, 2020, the Company issued the following shares, net of share issuance costs, as a result of business combinations, milestones being met, and other equity-settled transactions: Number of shares Share capital Share based reserve Completion of acquisition milestones 751,922 $ 12,079 $ (12,079 ) Other issuances 412,417 14,135 (14,719 ) Total 1,164,339 $ 26,214 $ (26,798 ) During the three months ended June 30, 2019, the Company issued the following shares, net of share issuance costs, as a result of business combinations, milestones being met, and other equity-settled transactions: Number of shares Share capital Share based reserve Completion of acquisition milestones 482,321 $ 18,674 $ (18,674 ) Other issuances - (74 ) - Total 482,321 $ 18,600 $ (18,674 ) (iii) Warrants Number of whole warrants Average exercise price Warrant value Balance outstanding at March 31, 2020 1 146,299,443 $ 52.44 $ 2,638,951 Exercise of warrants (18,876,901 ) 12.98 (70,266 ) Balance outstanding at June 30, 2020 1 127,422,542 $ 58.29 $ 2,568,685 1 Number of whole warrants Average exercise price Warrant value Balance outstanding at March 31, 2019 107,848,322 $ 43.80 $ 1,589,925 Tranche A warrant modification - - 1,049,153 Issuance of Tranche B warrants 38,454,444 76.68 - Exercise of warrants (12,060 ) 35.36 (470 ) Balance outstanding at June 30, 2019 1 146,290,706 $ 52.44 $ 2,638,608 1 CANOPY RIVERS Authorized capital Canopy Rivers Inc. (“Canopy Rivers”) is authorized to issue an unlimited number of Class A common shares designated as subordinated voting shares (the “Subordinated Voting Shares”) and unlimited number of Class B common shares designated as multiple voting shares (the “Multiple Voting Shares”). Each Subordinated Voting Share carries the right to one vote per share and each Multiple Voting Share carries the right to 20 votes per share at all meetings of the shareholders of Canopy Rivers. There is no priority or distinction between the two classes of shares in respect of their entitlement to the payment of dividends or participation on liquidation, dissolution or winding-up of Canopy Rivers. Issued and outstanding As at June 30, 2020, Canopy Rivers had 36,468,318 Multiple Voting Shares (March 31, 2020 – 36,468,318) and 153,500,256 Subordinated Voting Shares (March 31, 2020 – 152,837,131) issued and outstanding. As at June 30, 2020, the Company held 36,468,318 Multiple Voting Shares (March 31, 2020 – 36,468,318) and 15,223,938 Subordinated Voting shares (March 31, 2020 – 15,223,938) which represented a 27.2% ownership interest in Canopy Rivers and 84.3% of the voting rights (March 31, 2020 – 27.3% and 84.4% respectively). The voting rights allow the Company to direct the relevant activities of Canopy Rivers such that the Company has control over Canopy Rivers and Canopy Rivers is consolidated in these financial statements. Financings There were no financings during the three months ended June 30, 2020, other than the release of shares related to share purchase financing as noted below. Initial financing 10,066,668 Subordinated Voting Shares were acquired by certain employees of the Company and another individual by way of share purchase loans, whereby funds were advanced to Canopy Rivers by the Company on behalf of such individuals. These Subordinated Voting Shares were initially accounted for as seed capital options and are not considered issued for accounting purposes until the loans are repaid on an individual employee/consultant basis. During the three months ended June 30, 2020, share purchase loans in the amount of $32 (three months ended June 30, 2019 – $19) relating to Canopy Rivers shares held in trust by the Company on behalf of certain Canopy Growth employees were repaid, resulting in the release from escrow of 638,891 Subordinated Voting Shares (three months ended June 30, 2019 – 377,775). As at June 30, 2020, there were 2,166,669 seed capital options outstanding (March 31, 2020 – 2,805,560). Please refer to Note 19 for additional details on the seed capital options Share buyback On April 2, 2020, Canopy Rivers received approval from the Toronto Stock Exchange (“TSX”) to commence a normal course issuer bid (“NCIB”) to purchase up to 10,409,961 Subordinated Voting Shares, representing 10% of Canopy Rivers’ issued and outstanding Subordinated Voting Shares, in the open market or as otherwise permitted by the TSX, subject to the normal terms and limitations of such bids. The NCIB will expire on April 1, 2021. Daily purchases are limited to 70,653 Subordinating Voting Shares, representing 25% of the average daily trading volume on the TSX over a specified period. The NCIB may be utilized at the sole discretion of Canopy Rivers, with no contractual obligation to purchase any specified number of shares. All Subordinated Voting Share purchases made by Canopy Rivers under the NCIB will be funded out of Canopy Rivers’ working capital and will be cancelled immediately. During the three months ended June 30, 2020, Canopy Rivers repurchased and cancelled a total of 109,100 Subordinated Voting Shares under the NCIB program for $125, at a weighted average acquisition price of $1.14 per share (three months ended June 30, 2019 – not applicable).

Share-Based Compensation

Share-Based Compensation	3 Months Ended
	Jun. 30, 2020
Disclosure Of Compensation Related Costs Sharebased Payments [Abstract]
Share-Based Compensation	19. SHARE-BASED COMPENSATION CANOPY GROWTH CORPORATION SHARE-BASED COMPENSATION PLAN Canopy Growth's eligible employees participate in a share-based compensation plan as noted below. On September 15, 2017, shareholders approved an Omnibus Incentive Plan (as amended and restated, the “Omnibus Plan”) pursuant to which the Company can issue share-based long-term incentives. On July 30, 2018, shareholders of the Company approved certain amendments to the Omnibus Plan in order to increase the maximum number of shares issuable under the Omnibus Plan. All directors, officers, employees and independent contractors of the Company are eligible to receive awards of common share purchase options (“Options”), restricted share units (“RSUs”), performance share units (“PSUs”), deferred share units, stock appreciation rights (“Stock Appreciation Rights”), performance awards (“Performance Awards”) or other stock based awards (collectively, the “Awards”) under the Omnibus Plan. In addition, shareholders also approved the 2017 Employee Stock Purchase Plan of the Company (the “Purchase Plan”). Under the Omnibus Plan, the maximum number of shares issuable from treasury pursuant to Awards shall not exceed 15% of the total outstanding shares from time to time less the number of shares issuable pursuant to all other security-based compensation arrangements of the Company. The maximum number of common shares reserved for Awards is 55,629,846 at June 30, 2020. As of June 30, 2020, the only Awards issued have been Options, RSUs and PSUs under the Omnibus Plan. The Omnibus Plan is administered by the Board of Directors of the Company who establishes exercise prices, at not less than the market price at the date of grant, and expiry dates. Options under the Omnibus Plan generally become exercisable in increments with 1/3 Under the Purchase Plan, the aggregate number of common shares that may be issued is 400,000, and the maximum number of common shares which may be issued in any one fiscal year shall not exceed 200,000. As of June 30, 2020, no common shares have been issued under the Purchase Plan. The following is a summary of the changes in the Options outstanding under the Omnibus Plan during the three months ended June 30, 2020: Options issued Weighted average exercise price Balance outstanding at March 31, 2020 32,508,395 $ 34.89 Options granted 155,800 22.20 Options exercised (711,472 ) 6.64 Options forfeited/cancelled (3,060,675 ) 39.37 Balance outstanding at June 30, 2020 28,892,048 $ 35.04 The following is a summary of the Options as at June 30, 2020: Options Outstanding Options Exercisable Range of Exercise Prices Outstanding at June 30, 2020 Weighted Average Remaining Contractual Life (years) Exercisable at June 30, 2020 Weighted Average Remaining Contractual Life (years) $0.06 - $24.62 5,494,833 3.37 3,415,917 2.74 $24.63 - $35.00 5,944,019 4.65 1,618,363 3.65 $35.01 - $36.80 5,941,004 4.33 2,589,127 4.12 $36.81 - $42.84 5,224,455 4.22 2,424,909 4.00 $42.85 - $67.64 6,287,737 4.65 1,511,022 4.44 28,892,048 4.26 11,559,338 3.67 At June 30, 2020, the weighted average exercise price of Options outstanding and Options exercisable was $35.04 and $31.60, respectively (March 31, 2020 – $34.89 and $31.84, respectively). The Company recorded $22,328 in share-based compensation expense related to Options issued to employees and contractors for the three months ended June 30, 2020 (three months ended June 30, 2019 – $73,093). The share-based compensation expense for the three months ended June 30, 2020 includes an amount related to 2,060,068 Options being provided in exchange for services which are subject to performance conditions (for the three months ended June 30, 2019 – The Company uses the Black-Scholes option pricing model to establish the fair value of Options granted during the three months ended June 30, 2020 and 2019, on their measurement date by applying the following assumptions: June 30, June 30, 2020 2019 Risk-free interest rate 0.33% 1.41% Expected life of options (years) 3 - 5 3 - 5 Expected volatility 76% 73% Expected forfeiture rate 16% 11% Expected dividend yield nil nil Black-Scholes value of each option $12.31 $28.58 Volatility was estimated by using the historical volatility of the Company. The expected life in years represents the period of time that Options granted are expected to be outstanding. The risk-free rate was based on zero coupon Canada government bonds with a remaining term equal to the expected life of the Options. During the three months ended June 30, 2020, 711,472 Options were exercised ranging in price from $1.32 to $27.99 for gross proceeds of $4,722 (for the three months ended June 30, 2019 – For the three months ended June 30, 2020, the Company recorded $3,842 in share-based compensation expense related to these RSUs (for the three months ended June 30, 2019 – $1,394). The following is a summary of the changes in the Company’s RSUs during the three months ended June 30, 2020: Number of RSUs Balance outstanding at March 31, 2020 883,009 RSUs cancelled and forfeited (50,871 ) Balance outstanding at June 30, 2020 832,138 Share-based compensation expense related to acquisition milestones is comprised of: Three months ended June 30, June 30, 2020 2019 Canindica $ 598 $ 4,010 Spectrum Colombia - 2,259 Other 2,372 4,012 $ 2,970 $ 10,281 During the three months ended June 30, 2020, 751,922 common shares (during the three months ended June 30, 2019 – 482,321) were released on completion of acquisition milestones. At June 30, 2020, there were up to 4,090,709 common shares to be issued on the completion of acquisition and asset purchase milestones. In certain cases, the number of common shares to be issued is based on the volume weighted average share price at the time the milestones are met. The number of common shares has been estimated assuming the milestones were met at June 30, 2020. The number of common shares excludes common shares that are to be issued on July 4, 2023 to the previous shareholders of Spectrum Colombia S.A.S. (“Spectrum Colombia”) and Canindica Capital Ltd. (“Canindica”) based on the fair market value of the Company’s Latin American business on that date. BioSteel share-based payments On October 1, 2019, the Company purchased 72% of the outstanding shares of BioSteel Sports Nutrition Inc. (“BioSteel”). BioSteel has a stock option plan under which non-transferable options to purchase common shares of BioSteel may be granted to directors, officers, employees, or independent contractors of the BioSteel. As at June 30, 2020, BioSteel had 1,014,000 (March 31, 2020 – 1,008,000) options outstanding which vest in equal tranches over a 5-year period. In determining the amount of share-based compensation related to these options, BioSteel used the Black-Scholes option pricing model to establish the fair value of options on their measurement date. The Company recorded $244 (three months ended June 30, 2019 – $nil) of share-based compensation expense related to the BioSteel options during the three months ended June 30, 2020 with a corresponding increase in noncontrolling interest. CANOPY RIVERS SHARE-BASED COMPENSATION PLAN Seed Capital Options On May 12, 2017, seed capital options were issued. These seed capital options consisted of 10,066,668 shares that were issued by way of share purchase loans. Since they were issued through loans, they are not considered issued for accounting purposes until the loan is repaid. The seed capital options were measured at fair value on May 12, 2017, using a Black-Scholes option pricing model and will be expensed over their vesting period. Where there are performance conditions in addition to service requirements Canopy Rivers has estimated the number of shares it expects to vest and is amortizing the expense over the expected vesting period. Seed capital options issued Seed capital loan balance Balance outstanding at March 31, 2020 2,805,560 $ 140 Options exercised (638,891 ) $ (32 ) Balance outstanding at June 30, 2020 2,166,669 $ 108 Canopy Rivers has a stock option plan (the “Option Plan”) under which non-transferable options to purchase Subordinated Voting Shares of the Company may be granted to directors, officers, employees, or independent contractors of Canopy Rivers. Pursuant to the Option Plan, the maximum number of Subordinated Voting Shares issuable from treasury pursuant to outstanding options shall not exceed 10% of the issued and outstanding Subordinated Voting Shares and Multiple Voting Shares, on an aggregate basis. The Option Plan is administered by the Board of Directors of Canopy Rivers who establishes exercise prices, at not less than the market price at the date of the grant, and expiry dates. Options under the Option Plan generally become exercisable in increments, with one-third being exercisable on each of the first, second, and third anniversaries from the date of grant, and have expiry dates five years from the date of grant. The Board of Directors of Canopy Rivers has the discretion to amend general vesting provisions and the term of any option grant, subject to limits contained in the Option Plan. The seed capital options are not within the scope of the Option Plan. The following is a summary of the changes in Canopy Rivers’ stock options, excluding the seed capital options presented separately, during the three months ended June 30, 2020: Options issued Weighted average exercise price Balance outstanding at March 31, 2020 13,066,004 $ 2.31 Options granted - - Options exercised (100,000 ) 0.60 Options expired (30,000 ) 3.50 Options forfeited/cancelled (218,334 ) 2.26 Balance outstanding at June 30, 2020 12,717,670 $ 2.32 In determining the amount of share-based compensation related to options issued during the year, Canopy Rivers used the Black-Scholes option pricing model to establish the fair value of options granted during the three months ended June 30, 2020 and 2019, on their measurement date by applying the following assumptions: June 30, June 30, 2020 2019 Risk-free interest rate - 1.35% Expected life of options (years) - 3 - 4 Expected volatility - 70% Expected forfeiture rate - nil Expected dividend yield - nil Black-Scholes value of each option - $1.93 Volatility was estimated using companies that Canopy Rivers considers comparable that have trading and volatility history prior to Canopy Rivers becoming public. The expected life in years represents the period of time that options granted are expected to be outstanding. The risk-free rate was based on zero coupon Canada government bonds with a remaining term equal to the expected life of the options. For the three months ended June 30, 2020, the Company recorded $1,184 (three months ended June 30, 2019 – $2,594) in share-based compensation expense related to these options and the seed capital options with a corresponding increase to noncontrolling interests. In the three months ended June 30, 2020, Canopy Rivers granted $225 (three months ended June 30, 2019 – $nil) worth of RSUs which vest over a one-year

Accumulated Other Comprehensive

Accumulated Other Comprehensive Income (Loss)	3 Months Ended
	Jun. 30, 2020
Equity [Abstract]
Accumulated Other Comprehensive Income (Loss)	20. ACCUMULATED OTHER COMPREHENSIVE INCOME (LOSS) Accumulated other comprehensive income includes the following components: Foreign currency translation adjustments Changes of own credit risk of financial liabilities Accumulated other comprehensive income (loss) As at March 31, 2020 $ 126,723 $ 94,176 $ 220,899 Other comprehensive loss (53,124 ) (15,360 ) (68,484 ) As at June 30, 2020 $ 73,599 $ 78,816 $ 152,415 Foreign currency translation adjustments Changes of own credit risk of financial liabilities Accumulated other comprehensive income (loss) As at March 31, 2019 $ 41,225 $ (47,130 ) $ (5,905 ) Other comprehensive (loss) income (60,744 ) 14,610 (46,134 ) As at June 30, 2019 $ (19,519 ) $ (32,520 ) $ (52,039 )

Noncontrolling Interests

Noncontrolling Interests	3 Months Ended
	Jun. 30, 2020
Noncontrolling Interest [Abstract]
Noncontrolling Interests	21. NONCONTROLLING INTERESTS The net change in the noncontrolling interests is as follows: Canopy Rivers Vert Mirabel BioSteel Other non- material interests Total As at March 31, 2020 $ 211,086 $ 7,132 $ 489 $ 3,051 $ 221,758 Comprehensive loss (3,883 ) (14,528 ) (1,410 ) - (19,821 ) Net loss attributable to redeemable noncontrolling interest - 9,253 1,410 - 10,663 Share-based compensation 1,301 - 244 - 1,545 Ownership changes 852 - - - 852 Warrants 250 - - - 250 As at June 30, 2020 $ 209,606 $ 1,857 $ 733 $ 3,051 $ 215,247 Canopy Rivers Vert Mirabel Other non- material interests Total As at March 31, 2019 $ 280,012 $ 2,422 $ 3,051 $ 285,485 Comprehensive (loss) income (12,431 ) 4,249 - (8,182 ) Net income attributable to redeemable noncontrolling interest - (2,715 ) - (2,715 ) Share-based compensation 2,594 - - 2,594 Ownership changes 236 - - 236 As at June 30, 2019 $ 270,411 $ 3,956 $ 3,051 $ 277,418

Fair Value of Financial Instrum

Fair Value of Financial Instruments	3 Months Ended
	Jun. 30, 2020
Fair Value Disclosures [Abstract]
Fair Value of Financial Instruments	22. FAIR VALUE OF FINANCIAL INSTRUMENTS Fair value measurements are made using a three-tier fair value hierarchy, which prioritizes the inputs used in measuring fair value: • Level 1 – defined as observable inputs such as quoted prices in active markets; • Level 2 – defined as inputs other than quoted prices in active markets that are either directly or indirectly observable; and • Level 3 – defined as unobservable inputs in which little or no market data exists, therefore requiring an entity to develop its own assumptions. The fair value measurement is categorized in its entirety by reference to its lowest level of significant input. The Company records cash, accounts receivable, interest receivable and, accounts payable, and other accrued expenses and liabilities at cost. The carrying values of these instruments approximate their fair value due to their short-term maturities. Unless otherwise noted, it is management's opinion that the Company is not exposed to significant interest or credit risks arising from these financial instruments. Assets and liabilities recognized or disclosed at fair value on a nonrecurring basis may include items such as property, plant and equipment, goodwill and other intangible assets, equity and other investments and other assets. We determine the fair value of these items using Level 3 inputs, as described in the related sections below. The following table represents our financial assets and liabilities measured at estimated fair value on a recurring basis: Fair value measurement using Quoted prices Significant prices in other Significant active observable unobservable markets inputs inputs (Level 1) (Level 2) (Level 3) Total June 30, 2020 Assets: Short-term investments $ 1,060,901 $ - $ - $ 1,060,901 Restricted short-term investments 16,436 - - 16,436 Other financial assets 1,602 55 217,257 218,914 Liabilities: Convertible senior notes - 485,898 - 485,898 Liability arising from Acreage Arrangement - - 285,000 285,000 Warrant derivative liability - - 287,122 287,122 March 31, 2020 Assets: Short-term investments $ 673,323 $ - $ - $ 673,323 Restricted short-term investments 21,539 - - 21,539 Other financial assets 2,596 36 192,473 195,105 Liabilities: Convertible senior notes - 450,204 - 450,204 Liability arising from Acreage Arrangement - - 250,000 250,000 Warrant derivative liability - - 322,491 322,491 The following table summarizes the valuation techniques and significant unobservable inputs in the fair value measurement of significant level 2 financial instruments: Financial asset / financial liability Valuation techniques Key inputs Convertible senior note Convertible note pricing model Quoted prices in over-the-counter broker market The following table summarizes the valuation techniques and significant unobservable inputs in the fair value measurement of significant level 3 financial instruments: Financial asset / financial liability Valuation techniques Significant unobservable inputs Relationship of unobservable inputs to fair value Acreage financial instrument Probability weighted expected return model Probability of each scenario Change in probability of occurrence in each scenario will result in a change in fair value Value and number of common shares to be issued Increase or decrease in value and number of common shares will result in a decrease or increase in fair value Probability and timing of US legalization Increase or decrease in probability of US legalization will result in an increase or decrease in fair value Estimated premium on US legalization Increase or decrease in estimated premium on US legalization will result in an increase or decrease in fair value Control premium Increase or decrease in estimated control premium will result in an increase or decrease in fair value Synergy value to Canopy Growth Increase or decrease in estimated synergy value to Canopy Growth will result in an increase or decrease in fair value TerrAscend exchangeable shares Put option pricing model Probability and timing of US legalization Increase or decrease in probability of US legalization will result in an increase or decrease in fair value TerrAscend warrants Monte Carlo simulation model Probability and timing of US legalization Increase or decrease in probability of US legalization will result in an increase or decrease in fair value TerrAscend Canada term loan Discounted cash flow Probability and timing of US legalization Increase or decrease in probability of US legalization will result in an increase or decrease in fair value ZeaKal shares Market approach Share price Increase or decrease in share price will result in an increase or decrease in fair value Greenhouse convertible debenture FinCAD model Share price Increase or decrease in share price will result in an increase or decrease in fair value Agripharm royalty interest and repayable debenture Discounted cash flow Discount rate Increase or decrease in discount rate will result in a decrease or increase in fair value Future royalties Increase or decrease in future royalties to be paid will result in an increase or decrease in fair value Warrant derivative liability Monte Carlo simulation model Volatility of common share price Increase or decrease in volatility will result in an increase or decrease in fair value Expected life Increase or decrease in expected life will result in an increase or decrease in fair value BioSteel redeemable noncontrolling interest Discounted cash flow Discount rate Increase or decrease in discount rate will result in a decrease or increase in fair value Future wholesale price and production levels Increase or decrease in future wholesale price and production levels will result in an increase or decrease in fair value Vert Mirabel redeemable noncontrolling interest Discounted cash flow Discount rate Increase or decrease in discount rate will result in a decrease or increase in fair value Future wholesale price and production levels Increase or decrease in future wholesale price and production levels will result in an increase or decrease in fair value During the three months ended June 30, 2020 and June 30, 2019, there were no transfers of amounts between levels

Revenue

Revenue	3 Months Ended
	Jun. 30, 2020
Revenue From Contract With Customer [Abstract]
Revenue	23. REVENUE Revenue is dissaggregated as follows: Three months ended June 30, June 30, 2020 2019 Recreational cannabis revenue Business to business $ 42,180 $ 50,425 Business to consumer 9,330 10,638 Medical cannabis revenue Canadian 15,336 13,051 International 20,191 10,496 Other revenue 32,051 18,781 Gross revenue 119,088 103,391 Excise taxes 8,672 12,909 Net revenue $ 110,416 $ 90,482 The Company recognizes variable consideration related to estimated future product returns and price adjustments as a reduction of the transaction price at the time revenue for the corresponding product sale is recognized. Net revenue reflects actual returns and variable consideration related to estimated returns and price adjustments in the amount of $3,400 for the three months ended June 30, 2020 (three months ended June 30, 2019 – $8,000). As of June 30, 2020, the liability for estimated returns and price adjustments was $8,433 (March 31, 2020 – $17,586).

Other Income (Expense), Net

Other Income (Expense), Net	3 Months Ended
	Jun. 30, 2020
Other Income And Expenses [Abstract]
Other Income (Expense), Net	24. OTHER INCOME (EXPENSE), NET Other income (expense), net is dissaggregated as follows: Three months ended June 30, June 30, 2020 2019 Fair value changes on other financial assets $ 21,807 $ (41,087 ) Fair value changes on liability arising from Acreage Arrangement (35,000 ) - Fair value changes on convertible senior notes (20,334 ) 31,446 Fair value change on warrant derivative liability 35,369 24,892 Fair value changes on acquisition related contingent consideration 39,983 (1,570 ) Interest income 8,993 22,718 Interest expense (1,155 ) (1,206 ) Foreign currency loss (5,959 ) (2,856 ) Other income, net 4,501 431 $ 48,205 $ 32,768

Income Taxes

Income Taxes	3 Months Ended
	Jun. 30, 2020
Income Tax Disclosure [Abstract]
Income Taxes	25. INCOME TAXES There have been no material changes to income tax matters in connection with normal course operations during the three months ended June 30, 2020. The Company is subject to income tax in numerous jurisdictions with varying income tax rates. During the most recent period ended and the fiscal year to date, there were no material changes to the statutory income tax rates in the taxing jurisdictions where the majority of the Company’s income for tax purposes was earned, or where its temporary differences or losses are expected to be realized or settled. Although statutory income tax rates remain stable, the Company’s effective income tax rate may fluctuate, arising as a result of the Company’s evolving footprint, discrete transactions and other factors that, to the extent material, are disclosed in these financial statements. The Company continues to believe the amount of unrealized tax benefits appropriately reflects the uncertainty of items that are or may in the future be under discussion, audit, dispute or appeal with a tax authority or which otherwise result in uncertainty in the determination of income for tax purposes. If appropriate, an unrealized tax benefit will be realized in the reporting period in which the Company determines that realization is not in doubt. Where the final determined outcome is different from the Company’s estimate, such difference will impact the Company’s income taxes in the reporting period during which such determination is made.

Acreage

Acreage	3 Months Ended
	Jun. 30, 2020
Business Combinations [Abstract]
Acreage Arrangement and Amendments to Cbi Investor Rights Agreement and Warrants	26. ACREAGE ARRANGEMENT AND AMENDMENTS TO CBI INVESTOR RIGHTS AGREEMENT AND WARRANTS Acreage Arrangement On June 24, 2020 the Company and Acreage Holdings, Inc. (“Acreage”) entered into a proposal agreement (the “Proposal Agreement”) to amend the terms of the arrangement (the “Existing Arrangement”) made pursuant to an arrangement agreement (the “Arrangement Agreement”) between the Company and Acreage dated April 18, 2019, as amended on May 15, 2019. Pursuant to the terms of the Existing Arrangement, shareholders of Acreage and holders of certain securities convertible into Existing SVS (as defined below) as of June 26, 2019, received an immediate aggregate total payment of US$300,000 ($395,190) in exchange for granting Canopy Growth both the right and the obligation (the “Acreage financial instrument”) to acquire all of the issued and outstanding shares of Acreage following the occurrence or waiver of changes in U.S. federal law to permit the general cultivation, distribution, and possession of marijuana or to remove the regulation of such activities from the federal laws of the United States (the “Triggering Event”) and subject to the satisfaction or waiver of the conditions set out in the Arrangement Agreement. Pursuant to the terms of the Proposal Agreement, the Existing Arrangement will be amended (the “Amended Arrangement”) to provide for, among other things, the following: • a capital reorganization of Acreage (the “Capital Reorganization”), pursuant to which Acreage will amend its Notice of Articles and Articles to, among other things, create the Fixed Shares (as defined below), the Floating Shares (as defined below) and the Fixed Multiple Shares (as defined below) and remove the existing Acreage subordinated voting shares (the “Existing SVS”), the existing Acreage proportionate voting shares (the “Existing PVS”) and the existing Acreage multiple voting shares (the “Existing MVS”). Pursuant to the Capital Reorganization (i) each outstanding Existing SVS will be exchanged for 0.7 of a Fixed Share and 0.3 of a Floating Share; (ii) each outstanding Existing PVS will be exchanged for 28 Fixed Shares and 12 Floating Shares; and (iii) each outstanding Existing MVS will be exchanged for 0.7 of a Fixed Multiple Share and 0.3 of a Floating Share; • The new Class E subordinated voting shares (the “Fixed Shares”) will have the same attributes as the Existing SVS and will be listed on the Canadian Securities Exchange (the “CSE”). Following the occurrence or waiver (at the discretion of Canopy Growth) of the Triggering Event and subject to the satisfaction or waiver of the conditions set out in the Arrangement Agreement (as modified in connection with the Amended Arrangement), Canopy Growth will acquire all of the issued and outstanding Fixed Shares based on an amended exchange ratio equal to 0.3048 of a common share to be received for each Fixed Share held (reduced from 0.5818 per Existing SVS pursuant to the Existing Agreement). The foregoing exchange ratio for the Fixed Shares is subject to adjustment in accordance with the Amended Arrangement if, among other things, Acreage issues greater than the permitted number of Fixed Shares; • The new Class D subordinated voting shares (the “Floating Shares”) will be listed on the CSE. Upon the occurrence or waiver (at the discretion of Canopy Growth) of the Triggering Event, Canopy Growth will have the right exercisable for a period of 30 days, to acquire all of the issued and outstanding Floating Shares for cash or common shares or a combination thereof, in Canopy Growth’s sole discretion at a price equal to the 30-day volume weighted average trading price of the Floating Shares on the CSE, subject to a minimum call price of US$6.41 per Floating Share. The foregoing exchange ratio for the Floating Shares is subject to adjustment in accordance with the Amended Arrangement if Acreage issues greater than the permitted number of Floating Shares. The acquisition of the Floating Shares, if acquired, will take place concurrently with the closing of the acquisition of the Fixed Shares; • The new Class F multiple voting shares (the “Fixed Multiple Shares”) will have the same attributes as the Existing MVS, provided that each Fixed Multiple Share will entitle the holder thereof to 4,300 votes per share at shareholder meetings of Acreage. Immediately prior to the acquisition of the Fixed Shares, each issued and outstanding Fixed Multiple Share will automatically be exchanges for one Fixed Share and thereafter be acquired by Canopy Growth upon the same terms and conditions as the acquisition of the Fixed Shares; • If the occurrence or waiver of the Triggering Event does not occur within 10 years from the date the Amended Arrangement is implemented, Canopy Growth’s rights to acquire both the Fixed Shares and the Floating Shares will terminate; • Upon implementation of the Amended Arrangement, Canopy Growth will make a cash payment to the shareholders of Acreage and holders of certain securities convertible into Existing SVS in the aggregate amount of US$37,500; and • Acreage is only permitted to issue an aggregate of up to 32,700,000 Fixed Shares and Floating Shares following the implementation of the Amended Arrangement Canopy Growth has also agreed to loan a wholly-owned subsidiary of Acreage (“Acreage Hempco”) up to US$100,000 pursuant to a secured debenture, of which US$50,000 will be subject to the satisfaction of certain conditions by Acreage Hempco. The secured debenture will bear interest at a rate of 6.1% per annum, and mature 10 years from the date the Amended Arrangement is implemented or such earlier date in accordance with the terms of the secured debenture. As at June 30, 2020, no amounts have been loaned to Acreage Hempco. Implementation of the Amended Arrangement is contingent upon obtaining the requisite prior approvals of the shareholders of Acreage and the Supreme Court of British Columbia and certain other closing conditions. At June 30, 2020, the Acreage financial instrument represents a financial liability of $285,000 (March 31, 2020 – $250,000), as the estimated fair value of the Acreage business is less than the estimated fair value of the consideration to be provided upon the exercise of the Acreage financial instrument. Fair value changes of $35,000 (three months ended June 30, 2019 – $nil) were recognized in other income (expense), net in the three months ended June 30, 2020 (see Note 24). The fair value determination includes a high degree of subjectivity and judgment, which results in significant estimation uncertainty. See Note 22 for additional details on how the fair value of the Acreage financial instrument is calculated on a recurring basis. From a measurement perspective, Canopy Growth has elected the fair value option under ASC 825 – Financial Instruments Amendment to the CBI Investor Rights Agreement and warrants On April 18, 2019, certain wholly-owned subsidiaries of CBI and Canopy Growth entered into a second amended and restated investor rights agreement and a consent agreement. In connection with these agreements, on June 27, 2019 Canopy Growth (i) extended the term of the first tranche of warrants, which allow CBI to acquire 88.5 million additional shares of Canopy Growth for a fixed price of $50.40 per share (the “Tranche A Warrants”), to November 1, 2023; and (ii) replaced the second tranche of warrants with two new tranches of warrants (the “Tranche B Warrants” and the “Tranche C Warrants”) as follows: • the Tranche B Warrants are exercisable to acquire 38.5 million common shares at a price of C$76.68 per common • the Tranche C Warrants are exercisable to acquire 12.8 million common shares at a price equal to the 5-day volume-weighted average price of the common shares immediately prior to exercise. In connection with the Tranche B Warrants and the Tranche C Warrants, Canopy Growth will provide CBI with a share repurchase credit of up to $1.583 billion on the aggregate exercise price of the Tranche B Warrants and Tranche C Warrants in the event that Canopy Growth does not purchase for cancellation the lesser of (i) 27,378,866 common shares, and (ii) common shares with a value of $1.583 billion, during the period commencing on April 18, 2019 and ending on the date that is 24 months after the date that CBI exercises all of the Tranche A Warrants. The share repurchase credit feature is accounted for as a derivative liability, with the fair value continuing to be $nil at June 30, 2020. The modifications to the Tranche A Warrants resulted in them meeting the definition of a derivative instrument under ASC 815 - Derivatives and Hedging The Tranche B Warrants are accounted for as derivative instruments measured at fair value in accordance with ASC 815. At June 30, 2020, the fair value of the warrant derivative liability is $287,122, and a gain of $35,369 (three months ended June 30, 2019 – gain of $24,892) has been recognized in other income (expense), net in the three months ended June 30, 2020 (see Note 24). The fair value determination includes a high degree of subjectivity and judgment, which results in significant estimation uncertainty. See Note 22 for additional details on how the fair value of the warrant derivative liability is calculated on a recurring basis. The Tranche C Warrants are accounted for as derivative instruments, with the fair value continuing to be $nil at June 30, 2020.

Segmented Information

Segmented Information	3 Months Ended
	Jun. 30, 2020
Segment Reporting [Abstract]
Segmented Information	27. SEGMENT INFORMATION Reportable segments The Company operates in two segments: 1) Cannabis, Hemp and Other Consumer Products, which encompasses the production, distribution and sale of a diverse range of cannabis, hemp-based, and other consumer products in Canada and internationally pursuant to applicable international and domestic legislation, regulations and permits; and 2) Canopy Rivers, a publicly-traded company in Canada, through which the Company provides growth capital and strategic support in the global cannabis sector, where federally lawful. Financial information for Canopy Rivers is included in the table below, and in Note 21. June 30, 2020 March 31, 2020 Ownership interest 27 % 27 % Cash and cash equivalents $ 43,915 $ 46,724 Prepaid expenses and other current assets 11,815 11,598 Investments in associates 46,291 50,543 Other financial assets 150,134 146,812 Other long-term assets 22,776 22,058 Other liabilities (2,737 ) (2,771 ) Noncontrolling interests (209,606 ) (211,086 ) Equity attributable to Canopy Growth $ 62,588 $ 63,878 Entity-wide disclosures All property, plant and equipment are located in Canada, except for $487,834 which is located outside of Canada as at June 30, 2020 (March 31, 2020 – $499,059). All revenues were principally generated in Canada during the three months ended June 30, 2020, except for $44,699 related to exported medical cannabis and cannabis related merchandise generated outside of Canada (three months ended June 30, 2019 – $22,541). For the three months ended June 30, 2020, one customer represented more than 10% of the Company’s net revenue (three months ended June 30, 2019 – one).

Summary of Significant Accounti

Summary of Significant Accounting Policies (Policies)	3 Months Ended
	Jun. 30, 2020
Accounting Policies [Abstract]
Principles of consolidation	Principles of consolidation The accompanying condensed interim consolidated financial statements include the accounts of the Company and all entities in which the Company either has a controlling voting interest or is the primary beneficiary of a variable interest entity. All intercompany accounts and transactions have been eliminated on consolidation. Information on the Company’s subsidiaries with noncontrolling interests is included in Note 21.
Variable interest entities	Variable interest entities A variable interest entity (“VIE”) is an entity that does not have sufficient equity at risk to finance its activities without additional subordinated financial support or is structured such that equity investors lack the ability to control the entity’s activities or do not substantially participate in the gains and losses of the entity. Upon inception of a contractual agreement, and thereafter, if a reconsideration event occurs, the Company performs an assessment to determine whether the arrangement contains a variable interest in an entity and whether that entity is a VIE. The primary beneficiary of a VIE is the party that has both the power to direct the activities that most significantly impact the VIE’s economic performance and the obligation to absorb losses or the right to receive benefits from the VIE that could potentially be significant to the VIE. Under Accounting Standards Codification (“ASC”) 810 – Consolidations
Equity method investments	Equity method investments Investments accounted for using the equity method include those investments where the Company (i) can exercise significant influence over the other entity and (ii) holds common stock and/or in-substance common stock of the other entity. Under the equity method, investments are carried at cost, and subsequently adjusted for the Company’s share of net income (loss), comprehensive income (loss) and distributions received from the investee. If the current fair value of an investment falls below its carrying amount, this may indicate that an impairment loss should be recorded. Any impairment losses recognized are not reversed in subsequent periods. Refer to Note 9 for additional information on the Company’s investments accounted for using the equity method.
Use of estimates	Use of estimates The preparation of these condensed interim consolidated financial statements and accompanying notes in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the amounts reported. Actual results could differ from those estimates.
Recently Adopted Accounting Pronouncements	Recently Adopted Accounting Pronouncements Measurement of Credit Losses on Financial Instruments In June 2016, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU”) 2016-13, Financial Instruments – Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments Canopy Growth adopted the new standard as of April 1, 2020. There was no impact of adopting ASU 2016-13 on the condensed interim consolidated financial statements. Fair Value Measurement In August 2018, the FASB issued ASU 2018-13, Disclosure Framework – Changes to the Disclosure Requirements for Fair Value Measurement (Topic 820) Accounting Guidance not yet adopted Income Taxes In December 2019, the FASB issued ASU 2019-12, Income Taxes (Topic 740): Simplifying the Accounting for Income Taxes In January 2020, the FASB issued ASU 2020-01, Investments-Equity Securities (Topic 321), Investments-Equity Method and Joint Ventures (Topic 323), and Derivatives and Hedging (Topic 815)

Cash and Cash Equivalents (Tabl

Cash and Cash Equivalents (Tables)	3 Months Ended
	Jun. 30, 2020
Cash And Cash Equivalents [Abstract]
Components of Cash and Cash Equivalents	The components of cash and cash equivalents are as follows: June 30, March 31, 2020 2020 Cash $ 508,047 $ 679,581 Cash equivalents 467,823 623,595 $ 975,870 $ 1,303,176

Short-term Investments (Tables)

Short-term Investments (Tables)	3 Months Ended
	Jun. 30, 2020
Short Term Investments [Abstract]
Components of Short-term Investments	The components of short-term investments are as follows: June 30, March 31, 2020 2020 Term deposits $ 626,470 $ 374,000 Government securities 195,789 226,087 Commercial paper and other 238,642 73,236 $ 1,060,901 $ 673,323

Amounts Receivable, Net (Tables

Amounts Receivable, Net (Tables)	3 Months Ended
	Jun. 30, 2020
Receivables [Abstract]
Components of Amounts Receivable, Net	The components of amounts receivable, net are as follows: June 30, March 31, 2020 2020 Accounts receivable, net $ 42,222 $ 51,166 Interest receivable 14,215 10,303 Indirect taxes receivable 5,348 22,982 Other receivables 10,793 5,704 $ 72,578 $ 90,155

Inventory (Tables)

Inventory (Tables)	3 Months Ended
	Jun. 30, 2020
Inventory Disclosure [Abstract]
Components of Inventory	The components of inventory are as follows: June 30, March 31, 2020 2020 Raw materials, packaging supplies and consumables $ 49,581 $ 75,507 Work in progress 260,028 255,934 Finished goods 80,191 59,645 $ 389,800 $ 391,086

Prepaid Expenses and Other As_2

Prepaid Expenses and Other Assets (Tables)	3 Months Ended
	Jun. 30, 2020
Prepaid Expense And Other Assets Current [Abstract]
Components of Prepaid and Other Assets	The components of prepaid expenses and other assets are as follows: June 30, March 31, 2020 2020 Prepaid expenses $ 51,202 $ 41,423 Deposits 18,752 7,773 Prepaid inventory 17,160 21,217 Other assets 11,248 14,681 $ 98,362 $ 85,094

Equity Method Investments (Tabl

Equity Method Investments (Tables)	3 Months Ended
	Jun. 30, 2020
Equity Method Investments And Joint Ventures [Abstract]
Summary of Changes in Investments in Associates that are Accounted for Using Equity Method	The following table presents changes in the Company’s investments in associates that are accounted for using the equity method in the three months ended June 30, 2020: Balance at Share of Balance at Ownership March 31, net (loss) June 30, Entity Instrument percentage 2020 income 2020 PharmHouse Shares 49% $ 37,025 $ (4,656 ) $ 32,369 More Life Shares 40% 10,300 - 10,300 CanapaR Shares 49% 8,500 (329 ) 8,171 Agripharm Shares 40% 5,000 (2,937 ) 2,063 Other Shares 18%-27% 5,018 733 5,751 $ 65,843 $ (7,189 ) $ 58,654
Summary of Financial Information of Equity Method Investments	Where the Company does not have the same reporting date as its investees, the Company will account for its investment one quarter in arrears. Accordingly, certain of the figures in the above table, including the Company’s share of the investee’s net income (loss), are based on the investees’ results for the three months ended March 31, 2020 (with respect to June 30, 2020) with adjustments for any signficant transactions. The following tables present current and non-current assets, current and non-current liabilities as well as revenues and net loss of the Company’s equity method investments as at and for the three months ended March 31, 2020: Current Non-current Current Non-current Entity assets assets liabilities liabilities Revenue Net loss PharmHouse $ 9,193 $ 167,022 $ 85,463 $ 80,176 $ - $ (9,019 ) CanapaR 14,006 11,328 2,126 - 110 (669 ) Agripharm 6,992 25,034 25,153 1,719 2,468 (7,342 ) Other 10,317 22,360 3,996 11,462 1,928 (2,588 ) $ 40,508 $ 225,744 $ 116,738 $ 93,357 $ 4,506 $ (19,618 )

Other Financial Assets (Tables)

Other Financial Assets (Tables)	3 Months Ended
	Jun. 30, 2020
Schedule Of Investments [Abstract]
Summary of Changes in Other Financial Assets	The following table outlines changes in other financial assets. Additional details on how the fair value of significant investments are calculated are included in Note 22. Exercise of Balance at options / Balance at March 31, Fair value disposal June 30, Entity Instrument 2020 Additions changes of shares 2020 TerrAscend Canada Term loan / debenture $ 53,820 $ - $ 10,960 $ - $ 64,780 TerrAscend Exchangeable shares 47,000 - 6,000 - 53,000 TerrAscend Warrants 25,004 - 10,306 - 35,310 PharmHouse Loan receivable 40,000 - - - 40,000 ZeaKal Shares 14,186 - (586 ) - 13,600 Agripharm Royalty interest 12,600 - 900 - 13,500 Greenhouse Convertible debenture 10,517 - (17 ) - 10,500 Other - classified as fair value through net income (loss) Various 22,495 481 (4,628 ) - 18,348 Other - elected as fair value through net income (loss) Various 9,483 1,519 (1,128 ) - 9,874 Other - classified as held for investment Loan receivable 14,148 600 - (36 ) 14,712 $ 249,253 $ 2,600 $ 21,807 $ (36 ) $ 273,624

Property, Plant and Equipment (

Property, Plant and Equipment (Tables)	3 Months Ended
	Jun. 30, 2020
Property Plant And Equipment [Abstract]
Summary of Expected Useful Life of Property, Plant and Equipment	The components of property, plant and equipment are as follows: June 30, March 31, 2020 2020 Buildings and greenhouses $ 880,329 $ 876,732 Production and warehouse equipment 287,002 300,666 Leasehold improvements 76,862 75,964 Land 71,355 65,003 Office and lab equipment 28,538 29,978 Computer equipment 31,844 30,744 Right-of-use-assets Buildings and greenhouses 148,743 169,754 Production and warehouse equipment 666 927 Assets in process 371,626 365,644 1,896,965 1,915,412 Less: Accumulated depreciation (388,297 ) (390,609 ) $ 1,508,668 $ 1,524,803

Intangible Assets (Tables)

Intangible Assets (Tables)	3 Months Ended
	Jun. 30, 2020
Intangible Assets Net Excluding Goodwill [Abstract]
Summary of Components of Intangible Assets	The components of intangible assets are as follows: June 30, 2020 March 31, 2020 Gross Net Gross Net Carrying Carrying Carrying Carrying Amount Amount Amount Amount Finite lived intangible assets Licensed brands $ 65,826 $ 49,218 $ 66,227 $ 53,797 Distribution channel 73,721 43,622 74,768 47,117 Health Canada and operating licenses 56,200 49,132 63,631 57,250 Intellectual property 220,142 190,843 240,386 215,044 Software and domain names 24,238 17,966 16,056 10,013 Amortizable intangibles in process 4,083 4,083 9,590 9,590 Total 444,210 354,864 470,658 392,811 Indefinite lived intangible assets Operating licenses $ 8,000 $ 7,000 Acquired brands 81,335 76,555 Total intangible assets $ 444,199 $ 476,366

Goodwill (Tables)

Goodwill (Tables)	3 Months Ended
	Jun. 30, 2020
Goodwill And Intangible Assets Disclosure [Abstract]
Changes in Carrying Amount of Goodwill	The changes in the carrying amount of goodwill are as follows: Balance, March 31, 2019 $ 1,489,859 Purchase accounting allocations 443,724 Finalization of S&B purchase price allocation (24,990 ) Foreign currency translation adjustments 45,878 Balance, March 31, 2020 1,954,471 Foreign currency translation adjustments (25,053 ) Balance, June 30, 2020 $ 1,929,418

Other Accrued Expenses and Li_2

Other Accrued Expenses and Liabilities (Tables)	3 Months Ended
	Jun. 30, 2020
Accounts Payable And Accrued Liabilities Current [Abstract]
Components of Other Accrued Expenses and Liabilities	The components of other accrued expenses and liabilities are as follows: June 30, March 31, 2020 2020 Property, plant and equipment $ 2,576 $ 1,173 Professional fees 15,725 7,677 Employee compensation 41,036 33,415 Other 23,644 22,729 $ 82,981 $ 64,994

Debt (Tables)

Debt (Tables)	3 Months Ended
	Jun. 30, 2020
Debt Disclosure [Abstract]
Summary of Components of Debt	The components of debt are as follows: Convertible senior notes June 30, March 31, Maturity Date 2020 2020 Convertible senior notes at 4.25% interest with semi-annual interest payments July 15, 2023 Principal amount $ 600,000 $ 600,000 Accrued interest 11,898 5,454 Non-credit risk fair value adjustment (13,230 ) (27,120 ) Credit risk fair value adjustment (112,770 ) (128,130 ) 485,898 450,204 Transferred receivables, bearing interest rate of EURIBOR plus 0.850% 4,439 4,678 Other revolving debt facility, loan, and financings 10,069 10,533 500,406 465,415 Less: current portion (22,570 ) (16,393 ) Long-term portion $ 477,836 $ 449,022

Other Liabilities (Tables)

Other Liabilities (Tables)	3 Months Ended
	Jun. 30, 2020
Other Liabilities Disclosure [Abstract]
Components of Other Liabilities	The components of other liabilities are as follows: As at June 30, 2020 As at March 31, 2020 Current Long-term Total Current Long-term Total Acquisition consideration related liabilities $ 52,318 $ 13,749 $ 66,067 $ 104,028 $ 9,791 $ 113,819 Lease liabilities 38,308 97,010 135,318 40,356 120,047 160,403 Minimum royalty obligations 11,437 49,043 60,480 9,368 50,445 59,813 Refund liability 8,433 - 8,433 17,586 - 17,586 Settlement liability 1,411 6,636 8,047 33,162 7,932 41,094 Other 12,850 1,801 14,651 11,309 2,445 13,754 $ 124,757 $ 168,239 $ 292,996 $ 215,809 $ 190,660 $ 406,469

Redeemable Noncontrolling Int_2

Redeemable Noncontrolling Interest (Tables)	3 Months Ended
	Jun. 30, 2020
Temporary Equity Disclosure [Abstract]
Summary of Net Change in Redeemable Noncontrolling Interests	The net changes in the redeemable noncontrolling interests are as follows: Vert Mirabel BioSteel Total As at March 31, 2020 $ 20,250 $ 49,500 $ 69,750 Loss attributable to noncontrolling interest (9,253 ) (1,410 ) (10,663 ) Adjustments to redemption amount 18,803 3,710 22,513 As at June 30, 2020 $ 29,800 $ 51,800 $ 81,600 Vert Mirabel As at March 31, 2019 $ 6,400 Income attributable to noncontrolling interest 2,715 Adjustments to redemption amount (615 ) As at June 30, 2019 $ 8,500

Share Capital (Tables)

Share Capital (Tables)	3 Months Ended
	Jun. 30, 2020
Equity [Abstract]
Summary of Issuances of Stock Other	During the three months ended June 30, 2020, the Company issued the following shares, net of share issuance costs, as a result of business combinations, milestones being met, and other equity-settled transactions: Number of shares Share capital Share based reserve Completion of acquisition milestones 751,922 $ 12,079 $ (12,079 ) Other issuances 412,417 14,135 (14,719 ) Total 1,164,339 $ 26,214 $ (26,798 ) During the three months ended June 30, 2019, the Company issued the following shares, net of share issuance costs, as a result of business combinations, milestones being met, and other equity-settled transactions: Number of shares Share capital Share based reserve Completion of acquisition milestones 482,321 $ 18,674 $ (18,674 ) Other issuances - (74 ) - Total 482,321 $ 18,600 $ (18,674 )
Summary of Warrants	Number of whole warrants Average exercise price Warrant value Balance outstanding at March 31, 2020 1 146,299,443 $ 52.44 $ 2,638,951 Exercise of warrants (18,876,901 ) 12.98 (70,266 ) Balance outstanding at June 30, 2020 1 127,422,542 $ 58.29 $ 2,568,685 1 Number of whole warrants Average exercise price Warrant value Balance outstanding at March 31, 2019 107,848,322 $ 43.80 $ 1,589,925 Tranche A warrant modification - - 1,049,153 Issuance of Tranche B warrants 38,454,444 76.68 - Exercise of warrants (12,060 ) 35.36 (470 ) Balance outstanding at June 30, 2019 1 146,290,706 $ 52.44 $ 2,638,608 1

Share-Based Compensation (Table

Share-Based Compensation (Tables)	3 Months Ended
	Jun. 30, 2020
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Summary of Outstanding Stock Options	The following is a summary of the Options as at June 30, 2020: Options Outstanding Options Exercisable Range of Exercise Prices Outstanding at June 30, 2020 Weighted Average Remaining Contractual Life (years) Exercisable at June 30, 2020 Weighted Average Remaining Contractual Life (years) $0.06 - $24.62 5,494,833 3.37 3,415,917 2.74 $24.63 - $35.00 5,944,019 4.65 1,618,363 3.65 $35.01 - $36.80 5,941,004 4.33 2,589,127 4.12 $36.81 - $42.84 5,224,455 4.22 2,424,909 4.00 $42.85 - $67.64 6,287,737 4.65 1,511,022 4.44 28,892,048 4.26 11,559,338 3.67
Summary of Assumptions Applied to Establish Fair Value of Options Granted Using Black-Scholes Option Pricing Model	The Company uses the Black-Scholes option pricing model to establish the fair value of Options granted during the three months ended June 30, 2020 and 2019, on their measurement date by applying the following assumptions: June 30, June 30, 2020 2019 Risk-free interest rate 0.33% 1.41% Expected life of options (years) 3 - 5 3 - 5 Expected volatility 76% 73% Expected forfeiture rate 16% 11% Expected dividend yield nil nil Black-Scholes value of each option $12.31 $28.58
Summary of Changes in RSUs	The following is a summary of the changes in the Company’s RSUs during the three months ended June 30, 2020: Number of RSUs Balance outstanding at March 31, 2020 883,009 RSUs cancelled and forfeited (50,871 ) Balance outstanding at June 30, 2020 832,138
Summary of Share-based Compensation Expense Related to Acquisition Milestones	Share-based compensation expense related to acquisition milestones is comprised of: Three months ended June 30, June 30, 2020 2019 Canindica $ 598 $ 4,010 Spectrum Colombia - 2,259 Other 2,372 4,012 $ 2,970 $ 10,281
Canopy Rivers Corporation
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Summary of Assumptions Applied to Establish Fair Value of Options Granted Using Black-Scholes Option Pricing Model	In determining the amount of share-based compensation related to options issued during the year, Canopy Rivers used the Black-Scholes option pricing model to establish the fair value of options granted during the three months ended June 30, 2020 and 2019, on their measurement date by applying the following assumptions: June 30, June 30, 2020 2019 Risk-free interest rate - 1.35% Expected life of options (years) - 3 - 4 Expected volatility - 70% Expected forfeiture rate - nil Expected dividend yield - nil Black-Scholes value of each option - $1.93
Omnibus Incentive Plan
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Summary of Changes in Employee Stock Options	The following is a summary of the changes in the Options outstanding under the Omnibus Plan during the three months ended June 30, 2020: Options issued Weighted average exercise price Balance outstanding at March 31, 2020 32,508,395 $ 34.89 Options granted 155,800 22.20 Options exercised (711,472 ) 6.64 Options forfeited/cancelled (3,060,675 ) 39.37 Balance outstanding at June 30, 2020 28,892,048 $ 35.04
Canopy Rivers Corporation Share Based Compensation Plan
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Summary of Changes in Employee Stock Options	The following is a summary of the changes in Canopy Rivers’ stock options, excluding the seed capital options presented separately, during the three months ended June 30, 2020: Options issued Weighted average exercise price Balance outstanding at March 31, 2020 13,066,004 $ 2.31 Options granted - - Options exercised (100,000 ) 0.60 Options expired (30,000 ) 3.50 Options forfeited/cancelled (218,334 ) 2.26 Balance outstanding at June 30, 2020 12,717,670 $ 2.32
Canopy Rivers Corporation Share Based Compensation Plan | Seed Capital Options
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Summary of Changes in Employee Stock Options	Seed capital options issued Seed capital loan balance Balance outstanding at March 31, 2020 2,805,560 $ 140 Options exercised (638,891 ) $ (32 ) Balance outstanding at June 30, 2020 2,166,669 $ 108

Accumulated Other Comprehensi_2

Accumulated Other Comprehensive Income (Loss) (Tables)	3 Months Ended
	Jun. 30, 2020
Equity [Abstract]
Accumulated Other Comprehensive Income	Accumulated other comprehensive income includes the following components: Foreign currency translation adjustments Changes of own credit risk of financial liabilities Accumulated other comprehensive income (loss) As at March 31, 2020 $ 126,723 $ 94,176 $ 220,899 Other comprehensive loss (53,124 ) (15,360 ) (68,484 ) As at June 30, 2020 $ 73,599 $ 78,816 $ 152,415 Foreign currency translation adjustments Changes of own credit risk of financial liabilities Accumulated other comprehensive income (loss) As at March 31, 2019 $ 41,225 $ (47,130 ) $ (5,905 ) Other comprehensive (loss) income (60,744 ) 14,610 (46,134 ) As at June 30, 2019 $ (19,519 ) $ (32,520 ) $ (52,039 )

Noncontrolling Interests (Table

Noncontrolling Interests (Tables)	3 Months Ended
	Jun. 30, 2020
Noncontrolling Interest [Abstract]
Summary of Net Change in Noncontrolling Interests	The net change in the noncontrolling interests is as follows: Canopy Rivers Vert Mirabel BioSteel Other non- material interests Total As at March 31, 2020 $ 211,086 $ 7,132 $ 489 $ 3,051 $ 221,758 Comprehensive loss (3,883 ) (14,528 ) (1,410 ) - (19,821 ) Net loss attributable to redeemable noncontrolling interest - 9,253 1,410 - 10,663 Share-based compensation 1,301 - 244 - 1,545 Ownership changes 852 - - - 852 Warrants 250 - - - 250 As at June 30, 2020 $ 209,606 $ 1,857 $ 733 $ 3,051 $ 215,247 Canopy Rivers Vert Mirabel Other non- material interests Total As at March 31, 2019 $ 280,012 $ 2,422 $ 3,051 $ 285,485 Comprehensive (loss) income (12,431 ) 4,249 - (8,182 ) Net income attributable to redeemable noncontrolling interest - (2,715 ) - (2,715 ) Share-based compensation 2,594 - - 2,594 Ownership changes 236 - - 236 As at June 30, 2019 $ 270,411 $ 3,956 $ 3,051 $ 277,418

Fair Value of Financial Instr_2

Fair Value of Financial Instruments (Tables)	3 Months Ended
	Jun. 30, 2020
Summary of Financial Assets and Liabilities Measured at Estimated Fair Value on a Recurring Basis	The following table represents our financial assets and liabilities measured at estimated fair value on a recurring basis: Fair value measurement using Quoted prices Significant prices in other Significant active observable unobservable markets inputs inputs (Level 1) (Level 2) (Level 3) Total June 30, 2020 Assets: Short-term investments $ 1,060,901 $ - $ - $ 1,060,901 Restricted short-term investments 16,436 - - 16,436 Other financial assets 1,602 55 217,257 218,914 Liabilities: Convertible senior notes - 485,898 - 485,898 Liability arising from Acreage Arrangement - - 285,000 285,000 Warrant derivative liability - - 287,122 287,122 March 31, 2020 Assets: Short-term investments $ 673,323 $ - $ - $ 673,323 Restricted short-term investments 21,539 - - 21,539 Other financial assets 2,596 36 192,473 195,105 Liabilities: Convertible senior notes - 450,204 - 450,204 Liability arising from Acreage Arrangement - - 250,000 250,000 Warrant derivative liability - - 322,491 322,491
Level 2
Summary of Valuation Techniques and Significant Unobservable Inputs in the Fair Value Measurement of Significant Level 2 and Level 3 Financial Instruments	The following table summarizes the valuation techniques and significant unobservable inputs in the fair value measurement of significant level 2 financial instruments: Financial asset / financial liability Valuation techniques Key inputs Convertible senior note Convertible note pricing model Quoted prices in over-the-counter broker market
Level 3
Summary of Valuation Techniques and Significant Unobservable Inputs in the Fair Value Measurement of Significant Level 2 and Level 3 Financial Instruments	The following table summarizes the valuation techniques and significant unobservable inputs in the fair value measurement of significant level 3 financial instruments: Financial asset / financial liability Valuation techniques Significant unobservable inputs Relationship of unobservable inputs to fair value Acreage financial instrument Probability weighted expected return model Probability of each scenario Change in probability of occurrence in each scenario will result in a change in fair value Value and number of common shares to be issued Increase or decrease in value and number of common shares will result in a decrease or increase in fair value Probability and timing of US legalization Increase or decrease in probability of US legalization will result in an increase or decrease in fair value Estimated premium on US legalization Increase or decrease in estimated premium on US legalization will result in an increase or decrease in fair value Control premium Increase or decrease in estimated control premium will result in an increase or decrease in fair value Synergy value to Canopy Growth Increase or decrease in estimated synergy value to Canopy Growth will result in an increase or decrease in fair value TerrAscend exchangeable shares Put option pricing model Probability and timing of US legalization Increase or decrease in probability of US legalization will result in an increase or decrease in fair value TerrAscend warrants Monte Carlo simulation model Probability and timing of US legalization Increase or decrease in probability of US legalization will result in an increase or decrease in fair value TerrAscend Canada term loan Discounted cash flow Probability and timing of US legalization Increase or decrease in probability of US legalization will result in an increase or decrease in fair value ZeaKal shares Market approach Share price Increase or decrease in share price will result in an increase or decrease in fair value Greenhouse convertible debenture FinCAD model Share price Increase or decrease in share price will result in an increase or decrease in fair value Agripharm royalty interest and repayable debenture Discounted cash flow Discount rate Increase or decrease in discount rate will result in a decrease or increase in fair value Future royalties Increase or decrease in future royalties to be paid will result in an increase or decrease in fair value Warrant derivative liability Monte Carlo simulation model Volatility of common share price Increase or decrease in volatility will result in an increase or decrease in fair value Expected life Increase or decrease in expected life will result in an increase or decrease in fair value BioSteel redeemable noncontrolling interest Discounted cash flow Discount rate Increase or decrease in discount rate will result in a decrease or increase in fair value Future wholesale price and production levels Increase or decrease in future wholesale price and production levels will result in an increase or decrease in fair value Vert Mirabel redeemable noncontrolling interest Discounted cash flow Discount rate Increase or decrease in discount rate will result in a decrease or increase in fair value Future wholesale price and production levels Increase or decrease in future wholesale price and production levels will result in an increase or decrease in fair value

Revenue (Tables)

Revenue (Tables)	3 Months Ended
	Jun. 30, 2020
Revenue From Contract With Customer [Abstract]
Summary of Disaggregation of Revenue	Revenue is dissaggregated as follows: Three months ended June 30, June 30, 2020 2019 Recreational cannabis revenue Business to business $ 42,180 $ 50,425 Business to consumer 9,330 10,638 Medical cannabis revenue Canadian 15,336 13,051 International 20,191 10,496 Other revenue 32,051 18,781 Gross revenue 119,088 103,391 Excise taxes 8,672 12,909 Net revenue $ 110,416 $ 90,482

Other Income (Expense), Net (Ta

Other Income (Expense), Net (Tables)	3 Months Ended
	Jun. 30, 2020
Other Income And Expenses [Abstract]
Schedule of Other Income (Expense), Net	Other income (expense), net is dissaggregated as follows: Three months ended June 30, June 30, 2020 2019 Fair value changes on other financial assets $ 21,807 $ (41,087 ) Fair value changes on liability arising from Acreage Arrangement (35,000 ) - Fair value changes on convertible senior notes (20,334 ) 31,446 Fair value change on warrant derivative liability 35,369 24,892 Fair value changes on acquisition related contingent consideration 39,983 (1,570 ) Interest income 8,993 22,718 Interest expense (1,155 ) (1,206 ) Foreign currency loss (5,959 ) (2,856 ) Other income, net 4,501 431 $ 48,205 $ 32,768

Segmented Information (Tables)

Segmented Information (Tables)	3 Months Ended
	Jun. 30, 2020
Segment Reporting [Abstract]
Summary of Financial Information for Canopy Rivers	Financial information for Canopy Rivers is included in the table below, and in Note 21. June 30, 2020 March 31, 2020 Ownership interest 27 % 27 % Cash and cash equivalents $ 43,915 $ 46,724 Prepaid expenses and other current assets 11,815 11,598 Investments in associates 46,291 50,543 Other financial assets 150,134 146,812 Other long-term assets 22,776 22,058 Other liabilities (2,737 ) (2,771 ) Noncontrolling interests (209,606 ) (211,086 ) Equity attributable to Canopy Growth $ 62,588 $ 63,878

Asset Impairment and Restruct_2

Asset Impairment and Restructuring Costs - Additonal Information (Details) $ in Thousands	3 Months Ended
	Jun. 30, 2020CAD ($)
Restructuring And Related Activities [Abstract]
Asset impairment and restructuring costs	$ 12,794

Cash and Cash Equivalents - Com

Cash and Cash Equivalents - Components of Cash and Cash Equivalents (Details) - CAD ($) $ in Thousands	Jun. 30, 2020	Mar. 31, 2020
Cash And Cash Equivalents [Abstract]
Cash	$ 508,047	$ 679,581
Cash equivalents	467,823	623,595
Cash And Cash Equivalents At Carrying Value	$ 975,870	$ 1,303,176

Short-term Investments - Compon

Short-term Investments - Components of Short-term Investments (Details) - CAD ($) $ in Thousands	Jun. 30, 2020	Mar. 31, 2020
Marketable Securities [Line Items]
Short-term investments	$ 1,060,901	$ 673,323
Term Deposits
Marketable Securities [Line Items]
Short-term investments	626,470	374,000
Government securities
Marketable Securities [Line Items]
Short-term investments	195,789	226,087
Commercial paper and other
Marketable Securities [Line Items]
Short-term investments	$ 238,642	$ 73,236

Short-term Investments - Additi

Short-term Investments - Additional Information (Details) - CAD ($) $ in Thousands	Jun. 30, 2020	Mar. 31, 2020
Short Term Investments [Abstract]
Amortized cost of short-term investments	$ 1,060,890	$ 673,022

Amounts Receivable, Net - Compo

Amounts Receivable, Net - Components of Amounts Receivable, Net (Details) - CAD ($) $ in Thousands	Jun. 30, 2020	Mar. 31, 2020
Receivables [Abstract]
Accounts receivable, net	$ 42,222	$ 51,166
Interest receivable	14,215	10,303
Indirect taxes receivable	5,348	22,982
Other receivables	10,793	5,704
Amounts receivable, net	$ 72,578	$ 90,155

Amounts Receivable, Net - Addit

Amounts Receivable, Net - Additional Information (Details) - CAD ($) $ in Thousands	Jun. 30, 2020	Mar. 31, 2020
Receivables [Abstract]
Allowance for doubtful accounts	$ 917	$ 655

Inventory - Components of Inven

Inventory - Components of Inventory (Details) - CAD ($) $ in Thousands	Jun. 30, 2020	Mar. 31, 2020
Inventory Disclosure [Abstract]
Raw materials, packaging supplies and consumables	$ 49,581	$ 75,507
Work in progress	260,028	255,934
Finished goods	80,191	59,645
Inventory	$ 389,800	$ 391,086

Inventory - Additional Informat

Inventory - Additional Information (Details) - CAD ($) $ in Thousands	3 Months Ended
	Jun. 30, 2020	Jun. 30, 2019
Inventory Disclosure [Abstract]
Inventory write-downs	$ 19,386	$ 4,789

Prepaid Expenses and Other As_3

Prepaid Expenses and Other Assets - Components of Prepaid and Other Assets (Details) - CAD ($) $ in Thousands	Jun. 30, 2020	Mar. 31, 2020
Prepaid Expense And Other Assets Current [Abstract]
Prepaid expenses	$ 51,202	$ 41,423
Deposits	18,752	7,773
Prepaid inventory	17,160	21,217
Other assets	11,248	14,681
Prepaid and other assets	$ 98,362	$ 85,094

Equity Method Investments - Sum

Equity Method Investments - Summary of Changes in Investments in Associates that are Accounted for Using Equity Method (Details) $ in Thousands	3 Months Ended
	Jun. 30, 2020CAD ($)
Schedule Of Equity Method Investments [Line Items]
Beginning balance	$ 65,843
Share of net loss	(7,189)
Ending balance	$ 58,654
PharmHouse
Schedule Of Equity Method Investments [Line Items]
Ownership percentage	49.00%
Beginning balance	$ 37,025
Share of net loss	(4,656)
Ending balance	$ 32,369
Agripharm
Schedule Of Equity Method Investments [Line Items]
Ownership percentage	40.00%
Beginning balance	$ 5,000
Share of net loss	(2,937)
Ending balance	$ 2,063
More Life
Schedule Of Equity Method Investments [Line Items]
Ownership percentage	40.00%
Beginning balance	$ 10,300
Ending balance	$ 10,300
CanapaR
Schedule Of Equity Method Investments [Line Items]
Ownership percentage	49.00%
Beginning balance	$ 8,500
Share of net loss	(329)
Ending balance	8,171
Other
Schedule Of Equity Method Investments [Line Items]
Beginning balance	5,018
Share of net loss	733
Ending balance	$ 5,751
Other | Minimum
Schedule Of Equity Method Investments [Line Items]
Ownership percentage	18.00%
Other | Maximum
Schedule Of Equity Method Investments [Line Items]
Ownership percentage	27.00%

Equity Method Investments - S_2

Equity Method Investments - Summary of Financial Information of Equity Method Investments (Details) - CAD ($) $ in Thousands	3 Months Ended
	Jun. 30, 2020	Mar. 31, 2020	Jun. 30, 2019
Schedule Of Equity Method Investments [Line Items]
Current assets	$ 2,613,947	$ 2,564,373
Current liabilities	319,676	420,589
Net loss	$ (128,322)		$ (194,051)
Equity Method Investment, Nonconsolidated Investee
Schedule Of Equity Method Investments [Line Items]
Current assets		40,508
Non-current assets		225,744
Current liabilities		116,738
Non-current liabilities		93,357
Revenue		4,506
Net loss		(19,618)
Equity Method Investment, Nonconsolidated Investee | PharmHouse
Schedule Of Equity Method Investments [Line Items]
Current assets		9,193
Non-current assets		167,022
Current liabilities		85,463
Non-current liabilities		80,176
Net loss		(9,019)
Equity Method Investment, Nonconsolidated Investee | Agripharm
Schedule Of Equity Method Investments [Line Items]
Current assets		6,992
Non-current assets		25,034
Current liabilities		25,153
Non-current liabilities		1,719
Revenue		2,468
Net loss		(7,342)
Equity Method Investment, Nonconsolidated Investee | CanapaR
Schedule Of Equity Method Investments [Line Items]
Current assets		14,006
Non-current assets		11,328
Current liabilities		2,126
Revenue		110
Net loss		(669)
Equity Method Investment, Nonconsolidated Investee | Other
Schedule Of Equity Method Investments [Line Items]
Current assets		10,317
Non-current assets		22,360
Current liabilities		3,996
Non-current liabilities		11,462
Revenue		1,928
Net loss		$ (2,588)

Other Financial Assets - Summar

Other Financial Assets - Summary of Changes in Other Financial Assets (Details) $ in Thousands	3 Months Ended
	Jun. 30, 2020CAD ($)
Schedule Of Investments [Line Items]
Beginning balance	$ 249,253
Additions	2,600
Fair value changes	21,807
Exercise of options / disposal of shares	(36)
Ending balance	273,624
TerrAscend | Warrants
Schedule Of Investments [Line Items]
Beginning balance	25,004
Fair value changes	10,306
Ending balance	35,310
TerrAscend | Exchangeable Shares
Schedule Of Investments [Line Items]
Beginning balance	47,000
Fair value changes	6,000
Ending balance	53,000
TerrAscend Canada | Term loan / debenture
Schedule Of Investments [Line Items]
Beginning balance	53,820
Fair value changes	10,960
Ending balance	64,780
PharmHouse | Loan Receivable
Schedule Of Investments [Line Items]
Beginning balance	40,000
Ending balance	40,000
Agripharm | Royalty Interest
Schedule Of Investments [Line Items]
Beginning balance	12,600
Fair value changes	900
Ending balance	13,500
ZeaKal | Shares
Schedule Of Investments [Line Items]
Beginning balance	14,186
Fair value changes	(586)
Ending balance	13,600
Greenhouse | Convertible Debenture
Schedule Of Investments [Line Items]
Beginning balance	10,517
Fair value changes	(17)
Ending balance	10,500
Other Classified as Fair Value Through Net Income (Loss) | Various
Schedule Of Investments [Line Items]
Beginning balance	22,495
Additions	481
Fair value changes	(4,628)
Ending balance	18,348
Other Elected as Fair Value Through Net Income (Loss) | Various
Schedule Of Investments [Line Items]
Beginning balance	9,483
Additions	1,519
Fair value changes	(1,128)
Ending balance	9,874
Other - Classified as Held for Investment | Loan Receivable
Schedule Of Investments [Line Items]
Beginning balance	14,148
Additions	600
Exercise of options / disposal of shares	(36)
Ending balance	$ 14,712

Property, Plant and Equipment -

Property, Plant and Equipment - Schedule of Components of Property, Plant and Equipment (Details) - CAD ($) $ in Thousands	Jun. 30, 2020	Mar. 31, 2020
Property Plant And Equipment [Line Items]
Property, plant and equipment, gross	$ 1,896,965	$ 1,915,412
Less: Accumulated depreciation	(388,297)	(390,609)
Property, plant and equipment, net	1,508,668	1,524,803
Buildings and Greenhouses
Property Plant And Equipment [Line Items]
Property, plant and equipment, gross	880,329	876,732
Buildings and Greenhouses | Right-of-Use-Assets
Property Plant And Equipment [Line Items]
Property, plant and equipment, gross	148,743	169,754
Production and Warehouse Equipment
Property Plant And Equipment [Line Items]
Property, plant and equipment, gross	287,002	300,666
Production and Warehouse Equipment | Right-of-Use-Assets
Property Plant And Equipment [Line Items]
Property, plant and equipment, gross	666	927
Leasehold Improvements
Property Plant And Equipment [Line Items]
Property, plant and equipment, gross	76,862	75,964
Land
Property Plant And Equipment [Line Items]
Property, plant and equipment, gross	71,355	65,003
Office and Lab Equipment
Property Plant And Equipment [Line Items]
Property, plant and equipment, gross	28,538	29,978
Computer Equipment
Property Plant And Equipment [Line Items]
Property, plant and equipment, gross	31,844	30,744
Assets in Process
Property Plant And Equipment [Line Items]
Property, plant and equipment, gross	$ 371,626	$ 365,644

Property, Plant and Equipment_2

Property, Plant and Equipment - Additional Information (Details) - CAD ($) $ in Thousands	3 Months Ended
	Jun. 30, 2020	Jun. 30, 2019
Property Plant And Equipment [Line Items]
Depreciation of property, plant and equipment	$ 17,415	$ 13,587
Cost of Goods Sold
Property Plant And Equipment [Line Items]
Depreciation of property, plant and equipment	14,786	9,316
Selling, General and Administrative Expenses
Property Plant And Equipment [Line Items]
Depreciation of property, plant and equipment	$ 2,629	$ 4,271

Intangible Assets - Summary of

Intangible Assets - Summary of Components of Intangible Assets (Details) - CAD ($) $ in Thousands	Jun. 30, 2020	Mar. 31, 2020
Intangible Assets Net Excluding Goodwill [Line Items]
Gross Carrying Amount	$ 444,210	$ 470,658
Net Carrying Amount	354,864	392,811
Total intangible assets	444,199	476,366
Licensed Brands
Intangible Assets Net Excluding Goodwill [Line Items]
Gross Carrying Amount	65,826	66,227
Net Carrying Amount	49,218	53,797
Distribution Channel
Intangible Assets Net Excluding Goodwill [Line Items]
Gross Carrying Amount	73,721	74,768
Net Carrying Amount	43,622	47,117
Health Canada and Operating Licenses
Intangible Assets Net Excluding Goodwill [Line Items]
Gross Carrying Amount	56,200	63,631
Net Carrying Amount	49,132	57,250
Intellectual Property
Intangible Assets Net Excluding Goodwill [Line Items]
Gross Carrying Amount	220,142	240,386
Net Carrying Amount	190,843	215,044
Software and Domain Names
Intangible Assets Net Excluding Goodwill [Line Items]
Gross Carrying Amount	24,238	16,056
Net Carrying Amount	17,966	10,013
Amortizable Intangibles in Process
Intangible Assets Net Excluding Goodwill [Line Items]
Gross Carrying Amount	4,083	9,590
Net Carrying Amount	4,083	9,590
Operating Licenses
Intangible Assets Net Excluding Goodwill [Line Items]
Indefinite lived intangible assets	8,000	7,000
Acquired Brands
Intangible Assets Net Excluding Goodwill [Line Items]
Indefinite lived intangible assets	$ 81,335	$ 76,555

Intangible Assets - Additional

Intangible Assets - Additional Information (Details) - CAD ($) $ in Thousands	3 Months Ended
	Jun. 30, 2020	Jun. 30, 2019
Finite Lived Intangible Assets [Line Items]
Amortization of intangible assets	$ 16,632	$ 7,165
Cost of Goods Sold
Finite Lived Intangible Assets [Line Items]
Amortization of intangible assets	702	12
Selling, General and Administrative Expenses
Finite Lived Intangible Assets [Line Items]
Amortization of intangible assets	$ 15,930	$ 7,153

Goodwill - Changes in Carrying

Goodwill - Changes in Carrying Amount of Goodwill (Details) - CAD ($) $ in Thousands	3 Months Ended	12 Months Ended
	Jun. 30, 2020	Mar. 31, 2020
Goodwill And Intangible Assets Disclosure [Abstract]
Beginning Balance	$ 1,954,471	$ 1,489,859
Purchase accounting allocations		443,724
Finalization of S&B purchase price allocation		(24,990)
Foreign currency translation adjustments	(25,053)	45,878
Ending Balance	$ 1,929,418	$ 1,954,471

Other Accrued Expenses and Li_3

Other Accrued Expenses and Liabilities - Components of Other Accrued Expenses and Liabilities (Details) - CAD ($) $ in Thousands	Jun. 30, 2020	Mar. 31, 2020
Accounts Payable And Accrued Liabilities Current [Abstract]
Property, plant and equipment	$ 2,576	$ 1,173
Professional fees	15,725	7,677
Employee compensation	41,036	33,415
Other	23,644	22,729
Other accrued expenses and liabilities	$ 82,981	$ 64,994

Debt - Summary of Components of

Debt - Summary of Components of Debt (Details) - CAD ($) $ in Thousands	3 Months Ended	12 Months Ended
	Jun. 30, 2020	Mar. 31, 2020
Debt Instrument [Line Items]
Other revolving debt facility, loan, and financings	$ 10,069	$ 10,533
Long Term Debt	500,406	465,415
Less: current portion	(22,570)	(16,393)
Long-term portion	477,836	449,022
Euribor [Member]
Debt Instrument [Line Items]
Transferred receivables, bearing interest rate of EURIBOR plus 0.850%	$ 4,439	4,678
4.25% Convertible Senior Notes [Member]
Debt Instrument [Line Items]
Convertible senior notes at 4.25%, Maturity Date	Jul. 15, 2023
Principal amount	$ 600,000	600,000
Accrued interest	11,898	5,454
Non-credit risk fair value adjustment	(13,230)	(27,120)
Credit risk fair value adjustment	(112,770)	(128,130)
Senior Notes	$ 485,898	$ 450,204

Debt - Summary of Components _2

Debt - Summary of Components of Debt (Parenthetical) (Details)	3 Months Ended
	Jun. 30, 2020
Euribor [Member]
Debt Instrument [Line Items]
Debt Instrument, Basis Spread on Variable Rate	0.85%
4.25% Convertible Senior Notes [Member]
Debt Instrument [Line Items]
Annual interest rate	4.25%

Debt - Additional Information (

Debt - Additional Information (Details)	Aug. 13, 2019CAD ($)	Jun. 20, 2018CAD ($)Trading_Day$ / shares	Jun. 30, 2020CAD ($)	Jun. 30, 2019CAD ($)
Debt Instrument [Line Items]
Transfer of Factoring receivables			$ 4,342,000
Secured borrowing associated with transfer of factoring receivables			$ 4,439,000
Tweed Farms Inc | Farm Credit Canada | Revolving Credit Facility
Debt Instrument [Line Items]
Interest at a rate			3.45%
Maturity date			Sep. 3, 2024
Line of credit facility, maximum borrowing capacity	$ 40,000,000
Extinguishment of debt, amount	$ 4,912,000
Debt facility outstanding balance			$ 5,268,000
Debt instrument, description of variable rate basis			prime rate plus 1.0%
Debt Instrument, Basis Spread on Variable Rate			1.00%
4.25% Convertible Senior Notes [Member]
Debt Instrument [Line Items]
Principal amount		$ 600,000,000
Interest at a rate		4.25%
Frequency of periodic payment team		semi-annually on January 15th and July 15th of each year commencing from January 15, 2019
Maturity date		Jul. 15, 2023
Convertible senior notes conversion time start from		Jan. 15, 2023
Conversion rate for every dollar one of principal amount of notes | $ / shares		$ 20.7577
Convertible, If-converted value in excess of principal		$ 1,000
Conversion price | $ / shares		$ 48.18
Debt Conversion, Description		(i) the market price of the Company common shares for at least 20 trading days during a period of 30 consecutive trading days ending on the last trading day of the preceding calendar quarter is greater than or equal to 130% of the conversion price on each applicable trading day, (ii) during the 5 business day period after any consecutive 5 trading day period (the “measurement period”) in which the trading price per $1 principal amount of the notes for each trading day in the measurement period was less than 98% of the product of the last reported sales price of the Company’s common shares and the conversion rate on each such trading day, (iii) the notes are called for redemption or (iv) upon occurrence of certain corporate events (“Fundamental Change”). A Fundamental Change occurred upon completion of the investment by Constellation Brands, Inc. (“CBI”) in November 2018, and no note holders surrendered any portion of their notes as at the repurchase date of December 5, 2018
Conversion price percentage		130.00%	130.00%
Convertible measurement period threshold trading days		5 days
Convertible measurement period threshold consecutive trading days		5 days
Convertible conversion price | $ / shares		$ 1
Maximum discount to last reported sales price		98.00%
Debt instrument, redemption, description			The Company cannot redeem the notes prior to July 20, 2021, except in the event of certain changes in Canadian tax law.
Debt instrument, redemption period, start date			Jul. 20, 2021
Debt instrument, redemption threshold trading days			20 days
Debt instrument, redemption threshold consecutive trading days			30 days
Number of trading days to provide notice of redemption			5 days
Debt instrument, redemption price, percentage			100.00%
Debt instrument, change in fair value of notes			$ 35,694,000	$ 46,056,000
Debt instrument, change in fair value of notes from contractual interest			$ 6,444,000	$ 6,444,000
4.25% Convertible Senior Notes [Member] | Minimum
Debt Instrument [Line Items]
Threshold consecutive trading days | Trading_Day		20
4.25% Convertible Senior Notes [Member] | Maximum
Debt Instrument [Line Items]
Threshold consecutive trading days | Trading_Day		30

Other Liabilities - Components

Other Liabilities - Components of Other Liabilities (Details) - CAD ($) $ in Thousands	Jun. 30, 2020	Mar. 31, 2020
Current
Acquisition consideration related liabilities, current	$ 52,318	$ 104,028
Lease liabilities, current	38,308	40,356
Minimum royalty obligations, current	11,437	9,368
Refund liability, current	8,433	17,586
Settlement liability, current	1,411	33,162
Other, current	12,850	11,309
Other liabilities, current	124,757	215,809
Long-term
Acquisition consideration related liabilities, long-term	13,749	9,791
Lease liabilities, long-term	97,010	120,047
Minimum royalty obligations, long-term	49,043	50,445
Settlement liability, long-term	6,636	7,932
Other, long-term	1,801	2,445
Other liabilities, long-term	168,239	190,660
Total
Acquisition consideration related liabilities	66,067	113,819
Lease liabilities	135,318	160,403
Minimum royalty obligations	60,480	59,813
Refund liability	8,433	17,586
Settlement liability	8,047	41,094
Other	14,651	13,754
Other liabilities	$ 292,996	$ 406,469

Redeemable Noncontrolling Int_3

Redeemable Noncontrolling Interest - Summary of Net Change in Redeemable Noncontrolling Interests (Details) - CAD ($) $ in Thousands	3 Months Ended
	Jun. 30, 2020	Jun. 30, 2019
Redeemable Noncontrolling Interest [Line Items]
Beginning balance	$ 69,750
Income (Loss) attributable to noncontrolling interest	(10,663)
Adjustments to redemption amount	22,513
Ending balance	81,600
Vert Mirabel
Redeemable Noncontrolling Interest [Line Items]
Beginning balance	20,250	$ 6,400
Income (Loss) attributable to noncontrolling interest	(9,253)	2,715
Adjustments to redemption amount	18,803	(615)
Ending balance	29,800	$ 8,500
Bio Steel
Redeemable Noncontrolling Interest [Line Items]
Beginning balance	49,500
Income (Loss) attributable to noncontrolling interest	(1,410)
Adjustments to redemption amount	3,710
Ending balance	$ 51,800

Share Capital - Additional Info

Share Capital - Additional Information (Details)	Apr. 02, 2020shares	Jun. 30, 2020CAD ($)$ / sharesshares	Jun. 30, 2019CAD ($)shares	Mar. 31, 2020shares
Class Of Stock [Line Items]
Number of equity financings		0	0
Financings other than release of shares related to share purchase financing | $		$ 0
Subordinated Voting Shares
Class Of Stock [Line Items]
Daily purchases of common shares, limit	70,653
Average daily trading volume	25.00%
Canopy Rivers
Class Of Stock [Line Items]
Common Stock, Voting Rights		Each Subordinated Voting Share carries the right to one vote per share and each Multiple Voting Share carries the right to 20 votes per share at all meetings of the shareholders of Canopy Rivers.
Ownership percentage		27.20%		27.30%
Voting rights percentage		84.30%		84.40%
Share purchase loan amount repaid | $		$ 32,000	$ 19,000
Seed capital options outstanding		2,166,669		2,805,560
Canopy Rivers | Multiple Voting Shares
Class Of Stock [Line Items]
Shares issued		36,468,318		36,468,318
Shares outstanding		36,468,318		36,468,318
Treasury shares		36,468,318		36,468,318
Canopy Rivers | Subordinated Voting Shares
Class Of Stock [Line Items]
Shares issued		153,500,256		152,837,131
Shares outstanding		153,500,256		152,837,131
Treasury shares		15,223,938		15,223,938
Shares acquired by way of share purchase loans		10,066,668
Number of shares released from escrow		638,891	377,775
Maximum number of shares authorized to be repurchased	10,409,961
Percentage of subordinated voting shares issuable from treasury	10.00%
NCIB expiration date	Apr. 1, 2021
Stock repurchased and cancelled, shares		109,100
Stock Repurchased And Cancelled Value | $		$ 125,000
Weighted Average price, per share | $ / shares		$ 1.14

Share Capital - Summary of Issu

Share Capital - Summary of Issuances of Stock Other (Details) - CAD ($) $ in Thousands	3 Months Ended
	Jun. 30, 2020	Jun. 30, 2019
Equity Class Of Treasury Stock [Line Items]
Number of shares	1,164,339	482,321
Completion of acquisition milestones, Number of shares	751,922	482,321
Share capital	$ 26,214	$ 18,600
Share based reserve	(26,798)	(18,674)
Share Capital
Equity Class Of Treasury Stock [Line Items]
Completion of acquisition milestones	12,079	18,674
Share-based Reserve
Equity Class Of Treasury Stock [Line Items]
Completion of acquisition milestones	$ (12,079)	(18,674)
Other Issuances
Equity Class Of Treasury Stock [Line Items]
Number of shares	412,417
Share capital	$ 14,135	$ (74)
Share based reserve	$ (14,719)

Share Capital - Summary of Warr

Share Capital - Summary of Warrants (Details) - CAD ($) $ / shares in Units, $ in Thousands	3 Months Ended
	Jun. 30, 2020	Jun. 30, 2019
Class Of Warrant Or Right [Line Items]
Number of whole warrants, Beginning balance	146,299,443	107,848,322
Number of whole warrants, Exercise of warrants	(18,876,901)	(12,060)
Number of whole warrants, Ending balance	127,422,542	146,290,706
Average exercise price, Beginning balance	$ 52.44	$ 43.80
Average exercise price, Exercise of warrants	12.98	35.36
Average exercise price, Ending balance	$ 58.29	$ 52.44
Warrant value, Beginning balance	$ 2,638,951	$ 1,589,925
Warrant value, Exercise of warrants	(70,266)	(470)
Warrant value, Ending balance	$ 2,568,685	2,638,608
Tranche A
Class Of Warrant Or Right [Line Items]
Warrant value, Warrant modification		$ 1,049,153
Tranche B
Class Of Warrant Or Right [Line Items]
Number of whole warrants, Issuance of warrants		38,454,444
Average exercise price, Issuance of warrants		$ 76.68

Share-Based Compensation - Addi

Share-Based Compensation - Additional Information (Details) - CAD ($) $ / shares in Units, $ in Thousands	Sep. 15, 2017	Jun. 30, 2020	Jun. 30, 2019	Mar. 31, 2020	Oct. 01, 2019	May 12, 2017
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Weighted average exercise price of options outstanding		$ 35.04		$ 34.89
Weighted average exercise price of options exercisable		$ 31.60		$ 31.84
Share-based compensation expense		$ 2,970	$ 10,281
Proceeds from exercise of stock options		$ 4,722	$ 16,077
Completion of acquisition milestones, Number of shares		751,922	482,321
Number of shares to be issued on completion of acquisition and asset purchase milestones		4,090,709
Stock options outstanding		28,892,048
Share-based compensation		$ 30,685	$ 87,362
Canopy Rivers Corporation
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Share-based compensation expense		$ 1,184	2,594
Common Class B
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Seed capital options issued						10,066,668
Bio Steel Sports Nutrition Inc
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Percentage of outstanding shares purchased					72.00%
Stock options outstanding		1,014,000		1,008,000
Vesting period		5 years
Share-based compensation		$ 244
Employee Stock Option
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Share-based compensation expense		$ 22,328	$ 73,093
Stock Option Subject To Performance Conditions
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Share-based compensation expense, options subject to performance conditions		2,060,068	595,000
RSUs
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Share-based compensation expense		$ 3,842	$ 1,394
RSUs | Canopy Rivers Corporation
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Share-based compensation expense		$ 117
Vesting period		1 year
Value of RSUs granted		$ 225
Omnibus Incentive Plan
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Number of common shares reserved for Awards		55,629,846
Options expiration period	6 years
Weighted average exercise price of options outstanding		$ 35.04		$ 34.89
Options exercised		711,472	1,713,592
Exercise price		$ 6.64
Proceeds from exercise of stock options		$ 4,722	$ 16,077
Stock options outstanding		28,892,048		32,508,395
Omnibus Incentive Plan | Share-based Payment Arrangement, Tranche One
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Percentage of options exercisable on each anniversaries from date of grant	33.33%
Omnibus Incentive Plan | Share-based Payment Arrangement, Tranche Two
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Percentage of options exercisable on each anniversaries from date of grant	33.33%
Omnibus Incentive Plan | Share-based Payment Arrangement, Tranche Three
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Percentage of options exercisable on each anniversaries from date of grant	33.33%
Omnibus Incentive Plan | Maximum
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Percentage of number of shares issuable from treasury pursuant to awards	15.00%
Exercise price		$ 27.99	$ 40.68
Omnibus Incentive Plan | Minimum
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Exercise price		$ 1.32	$ 0.22
Employee Stock Purchase Plan
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Aggregate number of common shares authorized	400,000
Equity shares issued to shareholders		0
Employee Stock Purchase Plan | Maximum
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Equity shares issued to shareholders	200,000
Canopy Rivers Corporation Share Based Compensation Plan
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Options expiration period		5 years
Weighted average exercise price of options outstanding		$ 2.32		$ 2.31
Options exercised		100,000
Exercise price		$ 0.60
Stock options outstanding		12,717,670		13,066,004
Canopy Rivers Corporation Share Based Compensation Plan | Share-based Payment Arrangement, Tranche One
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Percentage of options exercisable on each anniversaries from date of grant		33.33%
Canopy Rivers Corporation Share Based Compensation Plan | Share-based Payment Arrangement, Tranche Two
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Percentage of options exercisable on each anniversaries from date of grant		33.33%
Canopy Rivers Corporation Share Based Compensation Plan | Share-based Payment Arrangement, Tranche Three
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Percentage of options exercisable on each anniversaries from date of grant		33.33%
Canopy Rivers Corporation Share Based Compensation Plan | Maximum
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Percentage of subordinated voting shares issuable from treasury		10.00%

Share-Based Compensation - Summ

Share-Based Compensation - Summary of the Changes in Options Outstanding Under the Omnibus Plan (Details) - shares	3 Months Ended
	Jun. 30, 2020	Jun. 30, 2019
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Options outstanding, ending balance	28,892,048
Omnibus Incentive Plan
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Options outstanding, beginning balance	32,508,395
Options granted	155,800
Options exercised	(711,472)	(1,713,592)
Options forfeited/cancelled	(3,060,675)
Options outstanding, ending balance	28,892,048

Share-Based Compensation - Su_2

Share-Based Compensation - Summary of the Changes in Omnibus Plan Employee Options (Details)	3 Months Ended
	Jun. 30, 2020$ / shares
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Weighted average exercise price outstanding, beginning balance	$ 34.89
Weighted average exercise price outstanding, ending balance	35.04
Omnibus Incentive Plan
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Weighted average exercise price outstanding, beginning balance	34.89
Weighted average exercise price, Options granted	22.20
Weighted average exercise price, Options exercised	6.64
Weighted average exercise price, Options forfeited/cancelled	39.37
Weighted average exercise price outstanding, ending balance	$ 35.04

Share-Based Compensation - Su_3

Share-Based Compensation - Summary of Outstanding Stock Options (Details)	3 Months Ended
	Jun. 30, 2020$ / sharesshares
Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range [Line Items]
Options Outstanding	28,892,048
Options Outstanding, Weighted Average Remaining Contractual Life	4 years 3 months 3 days
Options Exercisable	11,559,338
Options Exercisable, Weighted Average Remaining Contractual Life	3 years 8 months 1 day
Range​ One
Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range [Line Items]
Range of Exercise Prices, Lower Range | $ / shares	$ 0.06
Range of Exercise Prices, Upper Range | $ / shares	$ 24.62
Options Outstanding	5,494,833
Options Outstanding, Weighted Average Remaining Contractual Life	3 years 4 months 13 days
Options Exercisable	3,415,917
Options Exercisable, Weighted Average Remaining Contractual Life	2 years 8 months 26 days
Range​ Two
Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range [Line Items]
Range of Exercise Prices, Lower Range | $ / shares	$ 24.63
Range of Exercise Prices, Upper Range | $ / shares	$ 35
Options Outstanding	5,944,019
Options Outstanding, Weighted Average Remaining Contractual Life	4 years 7 months 24 days
Options Exercisable	1,618,363
Options Exercisable, Weighted Average Remaining Contractual Life	3 years 7 months 24 days
Range ​Three
Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range [Line Items]
Range of Exercise Prices, Lower Range | $ / shares	$ 35.01
Range of Exercise Prices, Upper Range | $ / shares	$ 36.80
Options Outstanding	5,941,004
Options Outstanding, Weighted Average Remaining Contractual Life	4 years 3 months 29 days
Options Exercisable	2,589,127
Options Exercisable, Weighted Average Remaining Contractual Life	4 years 1 month 13 days
Range​ Four
Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range [Line Items]
Range of Exercise Prices, Lower Range | $ / shares	$ 36.81
Range of Exercise Prices, Upper Range | $ / shares	$ 42.84
Options Outstanding	5,224,455
Options Outstanding, Weighted Average Remaining Contractual Life	4 years 2 months 19 days
Options Exercisable	2,424,909
Options Exercisable, Weighted Average Remaining Contractual Life	4 years
Range​ Five
Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range [Line Items]
Range of Exercise Prices, Lower Range | $ / shares	$ 42.85
Range of Exercise Prices, Upper Range | $ / shares	$ 67.64
Options Outstanding	6,287,737
Options Outstanding, Weighted Average Remaining Contractual Life	4 years 7 months 24 days
Options Exercisable	1,511,022
Options Exercisable, Weighted Average Remaining Contractual Life	4 years 5 months 8 days

Share-Based Compensation - Su_4

Share-Based Compensation - Summary of Assumptions Applied to Establish Fair Value of Options Granted Using Black-Scholes Option Pricing Model (Details) - $ / shares	3 Months Ended
	Jun. 30, 2020	Jun. 30, 2019
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Risk-free interest rate	0.33%	1.41%
Expected volatility	76.00%	73.00%
Expected forfeiture rate	16.00%	11.00%
Black-Scholes value of each option	$ 12.31	$ 28.58
Canopy Rivers Corporation Share Based Compensation Plan
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Risk-free interest rate		1.35%
Expected volatility		70.00%
Black-Scholes value of each option		$ 1.93
Minimum
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Expected life of options (years)	3 years	3 years
Minimum | Canopy Rivers Corporation Share Based Compensation Plan
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Expected life of options (years)		3 years
Maximum
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Expected life of options (years)	5 years	5 years
Maximum | Canopy Rivers Corporation Share Based Compensation Plan
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Expected life of options (years)		5 years

Share-Based Compensation - Su_5

Share-Based Compensation - Summary of the Changes in RSUs (Details) - RSUs	3 Months Ended
	Jun. 30, 2020shares
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Beginning balance	883,009
RSUs cancelled and forfeited	(50,871)
Ending balance	832,138

Share-Based Compensation - Su_6

Share-Based Compensation - Summary of Share-based Compensation Expense Related to Acquisition Milestones (Details) - CAD ($) $ in Thousands	3 Months Ended
	Jun. 30, 2020	Jun. 30, 2019
Employee Service Share Based Compensation Allocation Of Recognized Period Costs [Line Items]
Share-based compensation expense	$ 2,970	$ 10,281
Canindica
Employee Service Share Based Compensation Allocation Of Recognized Period Costs [Line Items]
Share-based compensation expense	598	4,010
Spectrum Colombia
Employee Service Share Based Compensation Allocation Of Recognized Period Costs [Line Items]
Share-based compensation expense		2,259
Other
Employee Service Share Based Compensation Allocation Of Recognized Period Costs [Line Items]
Share-based compensation expense	$ 2,372	$ 4,012

Share-Based Compensation - Su_7

Share-Based Compensation - Summary of Change in Seed Capital Options (Details) - CAD ($) $ in Thousands	3 Months Ended
	Jun. 30, 2020	Jun. 30, 2019
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Options outstanding, ending balance	28,892,048
Seed capital loan, options exercised	$ (4,722)	$ (16,077)
Canopy Rivers Corporation Share Based Compensation Plan
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Options outstanding, beginning balance	13,066,004
Options exercised	(100,000)
Options outstanding, ending balance	12,717,670
Seed Capital Options | Canopy Rivers Corporation Share Based Compensation Plan
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Options outstanding, beginning balance	2,805,560
Options exercised	(638,891)
Options outstanding, ending balance	2,166,669
Seed capital loan, beginning balance	$ 140
Seed capital loan, options exercised	(32)
Seed capital loan, ending balance	$ 108

Share-Based Compensation - Su_8

Share-Based Compensation - Summary of Changes in Canopy Rivers' Stock Options (Details)	3 Months Ended
	Jun. 30, 2020$ / sharesshares
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Options outstanding, ending balance | shares	28,892,048
Weighted average exercise price outstanding, beginning balance	$ 34.89
Weighted average exercise price outstanding, ending balance	$ 35.04
Canopy Rivers Corporation Share Based Compensation Plan
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Options outstanding, beginning balance | shares	13,066,004
Options exercised | shares	(100,000)
Options expired | shares	(30,000)
Options forfeited/cancelled | shares	(218,334)
Options outstanding, ending balance | shares	12,717,670
Weighted average exercise price outstanding, beginning balance	$ 2.31
Weighted average exercise price, Options exercised	0.60
Weighted average exercise price, Options expired	3.50
Weighted average exercise price, Options forfeited/cancelled	2.26
Weighted average exercise price outstanding, ending balance	$ 2.32

Accumulated Other Comprehensi_3

Accumulated Other Comprehensive Income (Loss) - Accumulated Other Comprehensive Income (Details) - CAD ($) $ in Thousands	3 Months Ended
	Jun. 30, 2020	Jun. 30, 2019
Accumulated Other Comprehensive Income Loss [Line Items]
Beginning balance	$ 5,108,120	$ 7,065,708
Other comprehensive (loss) income	(68,484)	(46,134)
Ending balance	5,180,541	5,809,663
Foreign Currency Translation Adjustments
Accumulated Other Comprehensive Income Loss [Line Items]
Beginning balance	126,723	41,225
Other comprehensive (loss) income	(53,124)	(60,744)
Ending balance	73,599	(19,519)
Changes of Own Credit Risk of Financial Liabilities
Accumulated Other Comprehensive Income Loss [Line Items]
Beginning balance	94,176	(47,130)
Other comprehensive (loss) income	(15,360)	14,610
Ending balance	78,816	(32,520)
Accumulated Other Comprehensive Income (Loss)
Accumulated Other Comprehensive Income Loss [Line Items]
Beginning balance	220,899	(5,905)
Ending balance	$ 152,415	$ (52,039)

Noncontrolling Interests - Summ

Noncontrolling Interests - Summary of Net Change in Noncontrolling Interests (Details) - CAD ($) $ in Thousands	3 Months Ended
	Jun. 30, 2020	Jun. 30, 2019
Minority Interest [Line Items]
Beginning balance	$ 5,108,120	$ 7,065,708
Comprehensive (loss) income	(19,821)	(8,182)
Net loss attributable to redeemable noncontrolling interest	10,663
Share-based compensation	30,685	87,362
Ending balance	5,180,541	5,809,663
Noncontrolling Interests
Minority Interest [Line Items]
Beginning balance	221,758	285,485
Comprehensive (loss) income	(19,821)	(8,182)
Net loss attributable to redeemable noncontrolling interest	10,663	(2,715)
Share-based compensation	1,545	2,594
Ownership changes	852	236
Warrants	250
Ending balance	215,247	277,418
Canopy Rivers
Minority Interest [Line Items]
Beginning balance	211,086	280,012
Comprehensive (loss) income	(3,883)	(12,431)
Share-based compensation	1,301	2,594
Ownership changes	852	236
Warrants	250
Ending balance	209,606	270,411
Vert Mirabel
Minority Interest [Line Items]
Beginning balance	7,132	2,422
Comprehensive (loss) income	(14,528)	4,249
Net loss attributable to redeemable noncontrolling interest	9,253	(2,715)
Ending balance	1,857	3,956
Bio Steel
Minority Interest [Line Items]
Beginning balance	489
Comprehensive (loss) income	(1,410)
Net loss attributable to redeemable noncontrolling interest	1,410
Share-based compensation	244
Ending balance	733
Other Non Material Interests
Minority Interest [Line Items]
Beginning balance	3,051	3,051
Ending balance	$ 3,051	$ 3,051

Fair Value of Financial Instr_3

Fair Value of Financial Instruments - Summary of Financial Assets and Liabilities Measured at Estimated Fair Value on a Recurring Basis (Details) - Fair Value Measurements Recurring - CAD ($) $ in Thousands	Jun. 30, 2020	Mar. 31, 2020
Assets:
Short-term investments	$ 1,060,901	$ 673,323
Restricted short-term investments	16,436	21,539
Other financial assets	218,914	195,105
Liabilities:
Convertible senior notes	485,898	450,204
Acreage
Liabilities:
Derivative liability	285,000	250,000
Warrant
Liabilities:
Derivative liability	287,122	322,491
Level 1
Assets:
Short-term investments	1,060,901	673,323
Restricted short-term investments	16,436	21,539
Other financial assets	1,602	2,596
Level 2
Assets:
Other financial assets	55	36
Liabilities:
Convertible senior notes	485,898	450,204
Level 3
Assets:
Other financial assets	217,257	192,473
Level 3 | Acreage
Liabilities:
Derivative liability	285,000	250,000
Level 3 | Warrant
Liabilities:
Derivative liability	$ 287,122	$ 322,491

Fair Value of Financial Instr_4

Fair Value of Financial Instruments - Summary of Valuation Techniques and Significant Unobservable Inputs in the Fair Value Measurement of Significant Level 2 Financial Instruments (Details) - Level 2 - Convertible Senior Notes	3 Months Ended
	Jun. 30, 2020
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]
Valuation techniques	Convertible note pricing model
Key inputs	Quoted prices in over-the-counter broker market

Fair Value of Financial Instr_5

Fair Value of Financial Instruments - Summary of Valuation Techniques and Significant Unobservable Inputs in the Fair Value Measurement of Significant Level 3 Financial Instruments (Details) - Level 3	3 Months Ended
	Jun. 30, 2020
Acreage Financial Instrument Probability of Each Scenario
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]
Valuation techniques	Probability weighted expected return model
Significant unobservable inputs	Probability of each scenario
Relationship of unobservable inputs to fair value	Change in probability of occurrence in each scenario will result in a change in fair value
Acreage Financial Instrument Value and Number of Canopy Shares Issued
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]
Significant unobservable inputs	Value and number of common shares to be issued
Relationship of unobservable inputs to fair value	Increase or decrease in value and number of common shares will result in a decrease or increase in fair value
Acreage Financial Instrument Intrinsic Value of Acreage
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]
Significant unobservable inputs	Probability and timing of US legalization
Relationship of unobservable inputs to fair value	Increase or decrease in probability of US legalization will result in an increase or decrease in fair value
Acreage Financial Instrument Probability and Timing of US Legalization
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]
Significant unobservable inputs	Estimated premium on US legalization
Relationship of unobservable inputs to fair value	Increase or decrease in estimated premium on US legalization will result in an increase or decrease in fair value
Acreage Financial Instrument Estimated Premium on US Legalization
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]
Significant unobservable inputs	Control premium
Relationship of unobservable inputs to fair value	Increase or decrease in estimated control premium will result in an increase or decrease in fair value
Acreage Financial Instrument Control Premium
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]
Significant unobservable inputs	Synergy value to Canopy Growth
Relationship of unobservable inputs to fair value	Increase or decrease in estimated synergy value to Canopy Growth will result in an increase or decrease in fair value
Terr Ascend Exchangeable Shares
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]
Valuation techniques	Put option pricing model
Significant unobservable inputs	Probability and timing of US legalization
Relationship of unobservable inputs to fair value	Increase or decrease in probability of US legalization will result in an increase or decrease in fair value
TerrAscend Warrants
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]
Valuation techniques	Monte Carlo simulation model
Significant unobservable inputs	Probability and timing of US legalization
Relationship of unobservable inputs to fair value	Increase or decrease in probability of US legalization will result in an increase or decrease in fair value
Terr Ascend Canada Term Loan
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]
Valuation techniques	Discounted cash flow
Significant unobservable inputs	Probability and timing of US legalization
Relationship of unobservable inputs to fair value	Increase or decrease in probability of US legalization will result in an increase or decrease in fair value
Zea Kal Shares
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]
Valuation techniques	Market approach
Significant unobservable inputs	Share price
Relationship of unobservable inputs to fair value	Increase or decrease in share price will result in an increase or decrease in fair value
Greenhouse Convertible Debenture
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]
Valuation techniques	FinCAD model
Significant unobservable inputs	Share price
Relationship of unobservable inputs to fair value	Increase or decrease in share price will result in an increase or decrease in fair value
Agripharm Royalty Interest and Repayable Debenture Discount Rate
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]
Valuation techniques	Discounted cash flow
Significant unobservable inputs	Discount rate
Relationship of unobservable inputs to fair value	Increase or decrease in discount rate will result in a decrease or increase in fair value
Agripharm Royalty Interest and Repayable Debenture Probability and Timing of U S Legalization
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]
Significant unobservable inputs	Future royalties
Relationship of unobservable inputs to fair value	Increase or decrease in future royalties to be paid will result in an increase or decrease in fair value
Warrant Derivative Liability Canopy Growth Share Price
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]
Valuation techniques	Monte Carlo simulation model
Significant unobservable inputs	Volatility of common share price
Relationship of unobservable inputs to fair value	Increase or decrease in volatility will result in an increase or decrease in fair value
Warrant Derivative Liability Volatility of Canopy Growth Share Price
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]
Significant unobservable inputs	Expected life
Relationship of unobservable inputs to fair value	Increase or decrease in expected life will result in an increase or decrease in fair value
BioSteel Redeemable Noncontrolling Interest Discount Rate
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]
Valuation techniques	Discounted cash flow
Significant unobservable inputs	Discount rate
Relationship of unobservable inputs to fair value	Increase or decrease in discount rate will result in a decrease or increase in fair value
BioSteel Redeemable Noncontrolling Interest Future Wholesale Price and Production Levels
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]
Significant unobservable inputs	Future wholesale price and production levels
Relationship of unobservable inputs to fair value	Increase or decrease in future wholesale price and production levels will result in an increase or decrease in fair value
Vert Mirabel Redeemable Noncontrolling Interest Discount Rate
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]
Valuation techniques	Discounted cash flow
Significant unobservable inputs	Discount rate
Relationship of unobservable inputs to fair value	Increase or decrease in discount rate will result in a decrease or increase in fair value
Vert Mirabel Redeemable Noncontrolling Interest Future Wholesale Price and Production Levels
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]
Significant unobservable inputs	Future wholesale price and production levels
Relationship of unobservable inputs to fair value	Increase or decrease in future wholesale price and production levels will result in an increase or decrease in fair value

Fair Value of Financial Instr_6

Fair Value of Financial Instruments - Additional Information (Details) - CAD ($)	Jun. 30, 2020	Jun. 30, 2019
Fair Value Disclosures [Abstract]
Fair value, transfers of amounts between levels	$ 0	$ 0

Revenue - Summary of Disaggrega

Revenue - Summary of Disaggregation of Revenue (Details) - CAD ($) $ in Thousands	3 Months Ended
	Jun. 30, 2020	Jun. 30, 2019
Disaggregation Of Revenue [Line Items]
Gross revenue	$ 119,088	$ 103,391
Excise taxes	8,672	12,909
Net revenue	110,416	90,482
Other Revenue
Disaggregation Of Revenue [Line Items]
Gross revenue	32,051	18,781
Canadian | Medical Cannabis Revenue
Disaggregation Of Revenue [Line Items]
Gross revenue	15,336	13,051
International | Medical Cannabis Revenue
Disaggregation Of Revenue [Line Items]
Gross revenue	20,191	10,496
Business to Business | Recreational Cannabis Revenue
Disaggregation Of Revenue [Line Items]
Gross revenue	42,180	50,425
Business to Consumer | Recreational Cannabis Revenue
Disaggregation Of Revenue [Line Items]
Gross revenue	$ 9,330	$ 10,638

Revenue - Additional Informatio

Revenue - Additional Information (Details) - CAD ($) $ in Thousands	3 Months Ended
	Jun. 30, 2020	Jun. 30, 2019	Mar. 31, 2020
Revenue From Contract With Customer [Abstract]
Allowance for estimated returns and price adjustments	$ 3,400	$ 8,000
Liability for estimated returns and price adjustments	$ 8,433		$ 17,586

Other Income (Expense), Net - S

Other Income (Expense), Net - Schedule of Other Income (Expense), Net (Details) - CAD ($) $ in Thousands	3 Months Ended
	Jun. 30, 2020	Jun. 30, 2019
Other Income And Expenses [Abstract]
Fair value changes on other financial assets	$ 21,807	$ (41,087)
Fair value changes on liability arising from Acreage Arrangement	(35,000)
Fair value changes on convertible senior notes	(20,334)	31,446
Fair value change on warrant derivative liability	35,369	24,892
Fair value changes on acquisition related contingent consideration	39,983	(1,570)
Interest income	8,993	22,718
Interest expense	(1,155)	(1,206)
Foreign currency loss	(5,959)	(2,856)
Other income, net	4,501	431
Other income (expense), net	$ 48,205	$ 32,768

Acreage Arrangement and Amendme

Acreage Arrangement and Amendments to Cbi Investor Rights Agreement and Warrants - Additional Information (Details)	Jun. 24, 2020USD ($)$ / sharesshares	Jun. 24, 2020USD ($)Vote / sharesshares	Jun. 27, 2019CAD ($)	Jun. 27, 2019USD ($)	Jun. 30, 2020CAD ($)	Jun. 30, 2019CAD ($)	Mar. 31, 2020CAD ($)	Apr. 18, 2019CAD ($)$ / sharesshares
Business Acquisition [Line Items]
Warrant expiration date								Nov. 1, 2023
Estimated fair value					$ (35,369,000)	$ (24,892,000)
Warrant
Business Acquisition [Line Items]
Derivative, financial liability					287,122,000		$ 322,491,000
Estimated fair value					35,369,000	24,892,000
Tranche A Warrants
Business Acquisition [Line Items]
Warrants to acquire shares | shares								88,500,000
Exercise price of warrants | $ / shares								$ 50.40
Tranche B Warrants
Business Acquisition [Line Items]
Warrants to acquire shares | shares								38,500,000
Exercise price of warrants | $ / shares								$ 76.68
Tranche C Warrants
Business Acquisition [Line Items]
Warrants to acquire shares | shares								12,800,000
Tranche B and C Warrants | Second Amended and Restated Investor Rights Agreement and Consent Agreement
Business Acquisition [Line Items]
Number of common stock shares to be repurchased to avoid providing repurchase credit | shares								27,378,866
Value of common stock to be repurchased to avoid providing repurchase credit								$ 1,583,000,000
Derivative liability					0
Maximum | Second Amended and Restated Investor Rights Agreement and Consent Agreement
Business Acquisition [Line Items]
Share repurchase credit limit								$ 1,583,000,000
Acreage
Business Acquisition [Line Items]
Aggregate payment		$ 37,500,000	$ 395,190,000	$ 300,000,000
Gain (Loss) on derivative, Net					35,000,000	$ 0
Acreage | Acreage Financial Instrument
Business Acquisition [Line Items]
Derivative, financial liability					285,000,000		$ 250,000,000
Acreage | Secured Debt
Business Acquisition [Line Items]
Credit facility	$ 50,000	$ 50,000			$ 0
Interest rate		6.10%
Debt instrument, Term		10 years
Acreage | Maximum
Business Acquisition [Line Items]
Number Of Fixed And Floating Shares Issued | shares	32,700,000	32,700,000
Acreage | Maximum | Secured Debt
Business Acquisition [Line Items]
Credit facility	$ 100,000	$ 100,000
Acreage | Subordinate Voting Shares | Fixed Shares
Business Acquisition [Line Items]
Common stock shares conversion ratio		0.7
Acreage | Subordinate Voting Shares | Floating Shares
Business Acquisition [Line Items]
Common stock shares conversion ratio		0.3
Acreage | Proportionate Voting Shares | Fixed Shares
Business Acquisition [Line Items]
Common stock shares conversion ratio		28
Acreage | Proportionate Voting Shares | Floating Shares
Business Acquisition [Line Items]
Common stock shares conversion ratio		12
Acreage | Multiple Voting Shares | Floating Shares
Business Acquisition [Line Items]
Common stock shares conversion ratio		0.3
Acreage | Multiple Voting Shares | Fixed Multiple Shares
Business Acquisition [Line Items]
Common stock shares conversion ratio		0.7
Acreage | Class E Subordinated Voting Shares | Fixed Shares
Business Acquisition [Line Items]
Common stock shares conversion ratio		0.3048	0.5818	0.5818
Acreage | Class D Subordinated Voting Shares | Floating Shares
Business Acquisition [Line Items]
Minimum call price | $ / shares	$ 6.41
Acreage | Class F Multiple Voting Shares | Fixed Multiple Shares
Business Acquisition [Line Items]
Voting Rights, Votes Per Share | Vote / shares		4,300

Segmented Information - Additio

Segmented Information - Additional Information (Details) $ in Thousands	3 Months Ended
	Jun. 30, 2020CAD ($)SegmentCustomer	Jun. 30, 2019CAD ($)Customer	Mar. 31, 2020CAD ($)
Segment Reporting Information [Line Items]
Number of operating segments | Segment	2
Property, plant and equipment	$ 1,508,668		$ 1,524,803
Customer Concentration Risk | Revenue from Contract with Customer Benchmark
Segment Reporting Information [Line Items]
Concentration risk customer number of customers | Customer	1	1
Non Canada
Segment Reporting Information [Line Items]
Property, plant and equipment	$ 487,834		$ 499,059
Revenue	$ 44,699	$ 22,541

Segmented Information - Summary

Segmented Information - Summary of Financial Information for Canopy Rivers (Details) - CAD ($) $ in Thousands	Jun. 30, 2020	Mar. 31, 2020
Segment Reporting Information [Line Items]
Cash and cash equivalents	$ 975,870	$ 1,303,176
Prepaid expenses and other current assets	98,362	85,094
Other financial assets	273,624	249,253
Other long-term assets	17,320	22,636
Other liabilities	(168,239)	(190,660)
Noncontrolling interests	(215,247)	(221,758)
Total Canopy Growth Corporation shareholders' equity	$ 4,965,294	$ 4,886,362
Canopy Rivers
Segment Reporting Information [Line Items]
Ownership percentage	27.00%	27.00%
Cash and cash equivalents	$ 43,915	$ 46,724
Prepaid expenses and other current assets	11,815	11,598
Investments in associates	46,291	50,543
Other financial assets	150,134	146,812
Other long-term assets	22,776	22,058
Other liabilities	(2,737)	(2,771)
Noncontrolling interests	(209,606)	(211,086)
Total Canopy Growth Corporation shareholders' equity	$ 62,588	$ 63,878